false 2021 Q1 0000003545 --09-30 P1Y P20D P20D P20D P20D P20D P20D P20D P20D P20D P20D P20D P12M P20D P20D P20D P20D P20D P20D 0 0 P3Y7M9D P1Y6M P4Y1M2D 0000003545 2020-10-01 2020-12-31 xbrli:shares 0000003545 2021-02-02 iso4217:USD 0000003545 2020-12-31 0000003545 2020-09-30 iso4217:USD xbrli:shares 0000003545 alco:AlicoCitrusMember 2020-10-01 2020-12-31 0000003545 alco:AlicoCitrusMember 2019-10-01 2019-12-31 0000003545 alco:WaterResourcesAndOtherOperationsMember 2020-10-01 2020-12-31 0000003545 alco:WaterResourcesAndOtherOperationsMember 2019-10-01 2019-12-31 0000003545 2019-10-01 2019-12-31 0000003545 us-gaap:CommonStockMember 2020-09-30 0000003545 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0000003545 us-gaap:TreasuryStockMember 2020-09-30 0000003545 us-gaap:RetainedEarningsMember 2020-09-30 0000003545 us-gaap:ParentMember 2020-09-30 0000003545 us-gaap:NoncontrollingInterestMember 2020-09-30 0000003545 us-gaap:RetainedEarningsMember 2020-10-01 2020-12-31 0000003545 us-gaap:ParentMember 2020-10-01 2020-12-31 0000003545 us-gaap:NoncontrollingInterestMember 2020-10-01 2020-12-31 0000003545 us-gaap:AdditionalPaidInCapitalMember srt:DirectorMember 2020-10-01 2020-12-31 0000003545 us-gaap:TreasuryStockMember srt:DirectorMember 2020-10-01 2020-12-31 0000003545 us-gaap:ParentMember srt:DirectorMember 2020-10-01 2020-12-31 0000003545 srt:DirectorMember 2020-10-01 2020-12-31 0000003545 us-gaap:AdditionalPaidInCapitalMember alco:ExecutivesAndManagersMember 2020-10-01 2020-12-31 0000003545 us-gaap:TreasuryStockMember alco:ExecutivesAndManagersMember 2020-10-01 2020-12-31 0000003545 us-gaap:ParentMember alco:ExecutivesAndManagersMember 2020-10-01 2020-12-31 0000003545 alco:ExecutivesAndManagersMember 2020-10-01 2020-12-31 0000003545 us-gaap:CommonStockMember 2020-12-31 0000003545 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000003545 us-gaap:TreasuryStockMember 2020-12-31 0000003545 us-gaap:RetainedEarningsMember 2020-12-31 0000003545 us-gaap:ParentMember 2020-12-31 0000003545 us-gaap:NoncontrollingInterestMember 2020-12-31 0000003545 us-gaap:CommonStockMember 2019-09-30 0000003545 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0000003545 us-gaap:TreasuryStockMember 2019-09-30 0000003545 us-gaap:RetainedEarningsMember 2019-09-30 0000003545 us-gaap:ParentMember 2019-09-30 0000003545 us-gaap:NoncontrollingInterestMember 2019-09-30 0000003545 2019-09-30 0000003545 us-gaap:RetainedEarningsMember 2019-10-01 2019-12-31 0000003545 us-gaap:ParentMember 2019-10-01 2019-12-31 0000003545 us-gaap:NoncontrollingInterestMember 2019-10-01 2019-12-31 0000003545 us-gaap:TreasuryStockMember 2019-10-01 2019-12-31 0000003545 us-gaap:AdditionalPaidInCapitalMember srt:DirectorMember 2019-10-01 2019-12-31 0000003545 us-gaap:TreasuryStockMember srt:DirectorMember 2019-10-01 2019-12-31 0000003545 us-gaap:ParentMember srt:DirectorMember 2019-10-01 2019-12-31 0000003545 srt:DirectorMember 2019-10-01 2019-12-31 0000003545 us-gaap:AdditionalPaidInCapitalMember alco:ExecutivesAndManagersMember 2019-10-01 2019-12-31 0000003545 us-gaap:ParentMember alco:ExecutivesAndManagersMember 2019-10-01 2019-12-31 0000003545 alco:ExecutivesAndManagersMember 2019-10-01 2019-12-31 0000003545 us-gaap:CommonStockMember 2019-12-31 0000003545 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000003545 us-gaap:TreasuryStockMember 2019-12-31 0000003545 us-gaap:RetainedEarningsMember 2019-12-31 0000003545 us-gaap:ParentMember 2019-12-31 0000003545 us-gaap:NoncontrollingInterestMember 2019-12-31 0000003545 2019-12-31 utr:acre 0000003545 us-gaap:LandMember 2020-12-31 alco:property alco:segment 0000003545 us-gaap:MiningPropertiesAndMineralRightsMember 2020-12-31 0000003545 alco:WestRanchMember 2020-09-30 0000003545 alco:CitrusOperationsMember 2020-12-31 0000003545 alco:CitrusOperationsMember 2020-09-30 0000003545 alco:EarlyAndMidSeasonMember alco:AlicoCitrusMember 2020-10-01 2020-12-31 0000003545 alco:EarlyAndMidSeasonMember alco:AlicoCitrusMember 2019-10-01 2019-12-31 0000003545 alco:FreshFruitMember alco:AlicoCitrusMember 2020-10-01 2020-12-31 0000003545 alco:FreshFruitMember alco:AlicoCitrusMember 2019-10-01 2019-12-31 0000003545 alco:CitrusGrovesMember alco:AlicoCitrusMember 2020-10-01 2020-12-31 0000003545 alco:CitrusGrovesMember alco:AlicoCitrusMember 2019-10-01 2019-12-31 0000003545 alco:OtherMember alco:AlicoCitrusMember 2020-10-01 2020-12-31 0000003545 alco:OtherMember alco:AlicoCitrusMember 2019-10-01 2019-12-31 0000003545 alco:LandAndOtherLeasingMember alco:WaterResourcesAndOtherOperationsMember 2020-10-01 2020-12-31 0000003545 alco:LandAndOtherLeasingMember alco:WaterResourcesAndOtherOperationsMember 2019-10-01 2019-12-31 0000003545 alco:OtherMember alco:WaterResourcesAndOtherOperationsMember 2020-10-01 2020-12-31 0000003545 alco:OtherMember alco:WaterResourcesAndOtherOperationsMember 2019-10-01 2019-12-31 0000003545 alco:CitreeHoldingsILLCMember 2020-10-01 2020-12-31 0000003545 alco:CitreeHoldingsILLCMember 2019-10-01 2019-12-31 xbrli:pure 0000003545 alco:CitreeHoldingsILLCMember 2019-12-31 0000003545 2019-10-01 2020-09-30 0000003545 2018-10-01 2019-09-30 0000003545 alco:EastAndWestRanchMember us-gaap:DiscontinuedOperationsHeldforsaleMember 2020-12-31 0000003545 alco:EastAndWestRanchMember us-gaap:DiscontinuedOperationsHeldforsaleMember 2020-09-30 0000003545 us-gaap:DiscontinuedOperationsHeldforsaleMember 2020-12-31 0000003545 us-gaap:DiscontinuedOperationsHeldforsaleMember 2020-09-30 0000003545 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember alco:EastRanchMember 2020-12-18 0000003545 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember alco:EastRanchMember 2020-12-18 2020-12-18 0000003545 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember alco:EastRanchMember 2020-10-01 2020-12-31 0000003545 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember alco:AlicoRanchMember 2020-09-10 0000003545 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember alco:AlicoRanchMember 2020-09-10 2020-09-10 0000003545 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember alco:EastRanchMember 2020-03-27 0000003545 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember alco:EastRanchMember 2020-03-27 2020-03-27 0000003545 alco:CitrusTreesMember 2020-12-31 0000003545 alco:CitrusTreesMember 2019-09-30 0000003545 us-gaap:MachineryAndEquipmentMember 2020-12-31 0000003545 us-gaap:MachineryAndEquipmentMember 2019-09-30 0000003545 us-gaap:BuildingAndBuildingImprovementsMember 2020-12-31 0000003545 us-gaap:BuildingAndBuildingImprovementsMember 2019-09-30 0000003545 alco:DepreciablePropertyPlantAndEquipmentMember 2020-12-31 0000003545 alco:DepreciablePropertyPlantAndEquipmentMember 2019-09-30 0000003545 us-gaap:LandAndLandImprovementsMember 2020-12-31 0000003545 us-gaap:LandAndLandImprovementsMember 2019-09-30 0000003545 alco:CitrusTreesMember 2020-10-01 2020-12-31 0000003545 alco:CitrusTreesMember 2018-10-01 2019-09-30 0000003545 2020-10-30 0000003545 2020-10-29 2020-10-30 0000003545 alco:WestRanchMember 2020-06-01 0000003545 alco:WestRanchMember 2020-05-31 2020-06-01 0000003545 alco:CitrusBlocksMember 2020-05-04 0000003545 alco:CitrusBlocksMember 2020-05-03 2020-05-04 0000003545 alco:FixedRateTermLoanMember 2020-12-31 0000003545 alco:FixedRateTermLoanMember 2020-09-30 0000003545 alco:VariableRateTermLoanMember 2020-12-31 0000003545 alco:VariableRateTermLoanMember 2020-09-30 0000003545 alco:CitreeTermLoanMember 2020-12-31 0000003545 alco:CitreeTermLoanMember 2020-09-30 0000003545 alco:PruLoansABMember 2020-12-31 0000003545 alco:PruLoansABMember 2020-09-30 0000003545 alco:PruLoanEMember 2020-12-31 0000003545 alco:PruLoanEMember 2020-09-30 0000003545 alco:TermLoansandPRULoansMember 2020-12-31 0000003545 alco:TermLoansandPRULoansMember 2020-09-30 0000003545 alco:WorkingCapitalLineOfCreditMember us-gaap:LineOfCreditMember 2020-12-31 0000003545 alco:WorkingCapitalLineOfCreditMember us-gaap:LineOfCreditMember 2020-09-30 0000003545 us-gaap:LineOfCreditMember 2020-12-31 0000003545 us-gaap:LineOfCreditMember 2020-09-30 0000003545 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-12-31 0000003545 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-09-30 0000003545 us-gaap:RevolvingCreditFacilityMember alco:FixedRateTermLoanMember 2020-12-31 0000003545 us-gaap:RevolvingCreditFacilityMember alco:VariableRateTermLoanMember 2020-12-31 0000003545 alco:MetropolitanLifeInsuranceCompanyAndNewEnglandLifeInsuranceCompanyRevolvingLineOfCreditMember 2020-12-31 0000003545 alco:WorkingCapitalLineOfCreditMember 2020-12-31 0000003545 alco:CitrusGrovesMember 2020-12-31 0000003545 alco:FarmandRanchLandMember 2020-12-31 0000003545 alco:FixedRateTermLoanMember 2020-10-01 2020-12-31 0000003545 alco:VariableRateTermLoanMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-10-01 2020-12-31 0000003545 alco:VariableRateTermLoanMember 2020-10-01 2020-12-31 0000003545 alco:MetropolitanLifeInsuranceCompanyAndNewEnglandLifeInsuranceCompanyRevolvingLineOfCreditMember alco:VariableRateTermLoanMember 2020-10-01 2020-12-31 0000003545 alco:MetropolitanLifeInsuranceCompanyAndNewEnglandLifeInsuranceCompanyRevolvingLineOfCreditMember alco:VariableRateTermLoanMember 2020-12-31 0000003545 alco:MetropolitanLifeInsuranceCompanyAndNewEnglandLifeInsuranceCompanyRevolvingLineOfCreditMember alco:VariableRateTermLoanMember 2020-09-30 0000003545 alco:MetropolitanLifeInsuranceCompanyAndNewEnglandLifeInsuranceCompanyRevolvingLineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-10-01 2020-12-31 0000003545 alco:MetropolitanLifeInsuranceCompanyAndNewEnglandLifeInsuranceCompanyRevolvingLineOfCreditMember 2020-10-01 2020-12-31 0000003545 alco:MetropolitanLifeInsuranceCompanyAndNewEnglandLifeInsuranceCompanyRevolvingLineOfCreditMember 2020-09-30 0000003545 alco:WorkingCapitalLineOfCreditMember 2020-09-30 0000003545 alco:WorkingCapitalLineOfCreditMember us-gaap:LetterOfCreditMember 2020-12-31 0000003545 alco:WorkingCapitalLineOfCreditMember srt:MinimumMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-10-01 2020-12-31 0000003545 alco:WorkingCapitalLineOfCreditMember srt:MaximumMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-10-01 2020-12-31 0000003545 alco:WorkingCapitalLineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-10-01 2020-12-31 0000003545 alco:WorkingCapitalLineOfCreditMember srt:MinimumMember 2020-10-01 2020-12-31 0000003545 alco:WorkingCapitalLineOfCreditMember srt:MaximumMember 2020-10-01 2020-12-31 0000003545 alco:WorkingCapitalLineOfCreditMember 2020-10-01 2020-12-31 0000003545 alco:WorkingCapitalLineOfCreditMember us-gaap:LetterOfCreditMember 2020-09-30 0000003545 us-gaap:RevolvingCreditFacilityMember 2014-09-30 0000003545 us-gaap:LetterOfCreditMember 2020-09-30 0000003545 us-gaap:RevolvingCreditFacilityMember 2020-12-31 0000003545 us-gaap:RevolvingCreditFacilityMember 2020-09-30 0000003545 alco:CitreeHoldingsILLCMember alco:MetlifeTermLoanMember 2020-12-31 0000003545 alco:CitreeHoldingsILLCMember alco:MetlifeTermLoanMember 2020-09-30 0000003545 alco:SilverNipCitrusMember alco:FixedRateTermLoanMember 2020-10-01 2020-12-31 0000003545 alco:SilverNipCitrusMember alco:FixedRateTermLoanMember 2020-12-31 alco:Loan 0000003545 alco:SilverNipCitrusMember alco:FixedRateTermLoanMember 2015-02-15 0000003545 alco:SilverNipCitrusMember alco:FixedRateTermLoanMember 2018-03-31 0000003545 alco:SilverNipCitrusMember alco:FixedRateTermLoanMember alco:PrudentialMortgageCapitalCompanyLLCMember 2020-10-01 2020-12-31 0000003545 alco:SilverNipCitrusMember alco:FixedRateTermLoan1Member 2014-09-04 0000003545 alco:SilverNipCitrusMember 2014-09-04 0000003545 alco:SilverNipCitrusMember alco:FixedRateTermLoanMember alco:PrudentialMortgageCapitalCompanyLLCMember 2014-09-04 0000003545 alco:SilverNipCitrusMember alco:FixedRateTermLoan2Member 2019-11-30 0000003545 alco:SilverNipCitrusMember alco:CitrusGrovesMember 2014-09-04 0000003545 alco:FixedRateTermLoanMember 2019-11-01 2019-11-30 0000003545 alco:SilverNipCitrusMember 2020-12-31 0000003545 alco:SilverNipCitrusDebtMember alco:SilverNipCitrusMember 2020-12-31 0000003545 alco:SilverNipCitrusDebtMember alco:SilverNipCitrusMember 2020-09-30 0000003545 us-gaap:OperatingSegmentsMember alco:AlicoCitrusMember 2020-10-01 2020-12-31 0000003545 us-gaap:OperatingSegmentsMember alco:AlicoCitrusMember 2019-10-01 2019-12-31 0000003545 us-gaap:OperatingSegmentsMember alco:LandAndOtherLeasingMember 2020-10-01 2020-12-31 0000003545 us-gaap:OperatingSegmentsMember alco:LandAndOtherLeasingMember 2019-10-01 2019-12-31 0000003545 us-gaap:MaterialReconcilingItemsMember 2020-10-01 2020-12-31 0000003545 us-gaap:MaterialReconcilingItemsMember 2019-10-01 2019-12-31 0000003545 alco:AlicoCitrusMember us-gaap:OperatingSegmentsMember 2020-12-31 0000003545 alco:AlicoCitrusMember us-gaap:OperatingSegmentsMember 2020-09-30 0000003545 alco:LandAndOtherLeasingMember 2020-12-31 0000003545 alco:LandAndOtherLeasingMember 2020-09-30 0000003545 us-gaap:CorporateNonSegmentMember 2020-12-31 0000003545 us-gaap:CorporateNonSegmentMember 2020-09-30 0000003545 alco:TwoThousandAndFifteenPlanMember 2015-02-27 0000003545 alco:TwoThousandAndFifteenPlanMember srt:MinimumMember 2020-10-01 2020-12-31 0000003545 alco:TwoThousandAndFifteenPlanMember srt:MaximumMember 2020-10-01 2020-12-31 0000003545 us-gaap:RestrictedStockMember 2020-10-01 2020-12-31 0000003545 us-gaap:RestrictedStockMember 2019-10-01 2019-12-31 0000003545 us-gaap:RestrictedStockMember 2020-12-31 0000003545 us-gaap:RestrictedStockMember 2020-09-30 0000003545 us-gaap:RestrictedStockMember alco:TwoThousandAndFifteenPlanMember 2020-11-10 2020-11-10 0000003545 us-gaap:RestrictedStockMember 2020-11-10 2020-11-10 0000003545 alco:TwoThousandAndTwentyPlanMember 2019-10-11 2019-10-11 0000003545 alco:TwoThousandAndTwentyPlanMember 2019-10-11 0000003545 alco:TwoThousandAndTwentyPlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2019-10-11 2019-10-11 0000003545 alco:TwoThousandAndTwentyPlanMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2019-10-11 2019-10-11 0000003545 alco:TwoThousandAndTwentyPlanMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2019-10-11 2019-10-11 0000003545 alco:TwoThousandAndTwentyPlanMember alco:SharebasedCompensationAwardTrancheFourMember 2019-10-11 2019-10-11 0000003545 alco:TwoThousandAndTwentyPlanMember srt:MaximumMember 2020-12-31 0000003545 alco:TwoThousandAndTwentyPlanMember srt:MinimumMember 2020-09-30 0000003545 alco:TwoThousandAndTwentyPlanMember 2019-10-01 2020-09-30 0000003545 alco:TwoThousandAndNineteenOptionGrantsMember srt:ChiefFinancialOfficerMember 2018-10-25 2018-10-25 0000003545 alco:TwoThousandAndNineteenOptionGrantsMember 2018-10-25 0000003545 alco:TwoThousandAndNineteenOptionGrantsMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2018-10-25 2018-10-25 0000003545 alco:TwoThousandAndNineteenOptionGrantsMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2018-10-25 2018-10-25 0000003545 alco:TwoThousandAndNineteenOptionGrantsMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2018-10-25 2018-10-25 0000003545 alco:TwoThousandAndNineteenOptionGrantsMember 2018-10-25 2018-10-25 0000003545 alco:TwoThousandAndNineteenOptionGrantsMember srt:MaximumMember 2020-12-31 0000003545 alco:TwoThousandAndNineteenOptionGrantsMember 2020-10-01 2020-12-31 0000003545 alco:TwoThousandAndEighteenOptionGrantsMember srt:ChiefExecutiveOfficerMember 2018-09-07 2018-09-07 0000003545 alco:TwoThousandAndEighteenOptionGrantsMember srt:ChiefFinancialOfficerMember 2018-09-07 2018-09-07 0000003545 alco:TwoThousandAndEighteenOptionGrantsMember 2018-09-07 0000003545 alco:TwoThousandAndEighteenOptionGrantsMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2018-09-07 2018-09-07 0000003545 alco:TwoThousandAndEighteenOptionGrantsMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2018-09-07 2018-09-07 0000003545 alco:TwoThousandAndEighteenOptionGrantsMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2018-09-07 2018-09-07 0000003545 alco:TwoThousandAndEighteenOptionGrantsMember alco:SharebasedCompensationAwardTrancheFourMember 2018-09-07 2018-09-07 0000003545 alco:TwoThousandAndEighteenOptionGrantsMember 2018-09-07 2018-09-07 0000003545 alco:TwoThousandAndEighteenOptionGrantsMember srt:MaximumMember 2020-12-31 0000003545 alco:TwoThousandAndEighteenOptionGrantsMember srt:MinimumMember 2020-09-30 0000003545 alco:TwoThousandAndEighteenOptionGrantsMember 2019-10-01 2020-09-30 0000003545 alco:TwoThousandAndEighteenOptionGrantsMember 2020-10-01 2020-12-31 0000003545 alco:TwoThousandAndSixteenOptionGrantsMember srt:ChiefExecutiveOfficerMember 2016-12-31 2016-12-31 0000003545 alco:TwoThousandAndSixteenOptionGrantsMember srt:BoardOfDirectorsChairmanMember 2016-12-31 2016-12-31 0000003545 alco:TwoThousandAndSixteenOptionGrantsMember 2016-12-31 0000003545 alco:TwoThousandAndSixteenOptionGrantsMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2016-12-31 2016-12-31 0000003545 alco:TwoThousandAndSixteenOptionGrantsMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2016-12-31 2016-12-31 0000003545 alco:TwoThousandAndSixteenOptionGrantsMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2016-12-31 2016-12-31 0000003545 alco:TwoThousandAndSixteenOptionGrantsMember alco:SharebasedCompensationAwardTrancheFourMember 2016-12-31 2016-12-31 0000003545 alco:TwoThousandAndSixteenOptionGrantsMember 2016-12-31 2016-12-31 0000003545 alco:TwoThousandAndSixteenOptionGrantsMember srt:MaximumMember 2020-12-31 0000003545 alco:TwoThousandAndSixteenOptionGrantsMember 2020-10-01 2020-12-31 0000003545 alco:TwoThousandAndSixteenOptionGrantsMember srt:BoardOfDirectorsChairmanMember 2018-09-05 2018-09-05 0000003545 alco:TwoThousandAndEighteenOptionGrantsMember srt:ChiefExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2019-02-11 2019-02-11 0000003545 alco:TwoThousandAndEighteenOptionGrantsMember srt:ChiefExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2019-02-11 2019-02-11 0000003545 alco:TwoThousandAndNineteenModifiedOptionGrantsMember srt:MaximumMember 2020-12-31 0000003545 alco:TwoThousandAndNineteenModifiedOptionGrantsMember srt:ChiefExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2019-02-11 2019-02-11 0000003545 alco:TwoThousandAndNineteenModifiedOptionGrantsMember srt:MaximumMember 2019-02-11 0000003545 alco:TwoThousandAndNineteenModifiedOptionGrantsMember srt:ChiefExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2019-02-11 2019-02-11 0000003545 us-gaap:EmployeeStockOptionMember 2020-10-01 2020-12-31 0000003545 us-gaap:EmployeeStockOptionMember 2019-10-01 2019-12-31 0000003545 us-gaap:EmployeeStockOptionMember 2020-12-30 0000003545 us-gaap:EmployeeStockOptionMember 2020-09-30 0000003545 alco:TwoThousandAndTwentyOptionGrantsMember us-gaap:EmployeeStockOptionMember 2020-10-01 2020-12-31 0000003545 us-gaap:EmployeeStockOptionMember alco:TwoThousandAndNineteenModifiedOptionGrantsMember 2020-10-01 2020-12-31 0000003545 alco:TwoThousandAndNineteenOptionGrantsMember us-gaap:EmployeeStockOptionMember 2020-10-01 2020-12-31 0000003545 2019-10-10 0000003545 us-gaap:FinancialStandbyLetterOfCreditMember 2020-12-31 0000003545 us-gaap:FinancialStandbyLetterOfCreditMember 2020-09-30 0000003545 srt:BoardOfDirectorsChairmanMember 2016-12-31 0000003545 srt:ExecutiveVicePresidentMember 2016-12-31 0000003545 srt:ChiefExecutiveOfficerMember 2019-02-11 2019-02-11 0000003545 srt:ChiefExecutiveOfficerMember 2020-10-01 2020-12-31 0000003545 us-gaap:MajorityShareholderMember alco:A734InvestorsMember 2019-11-12

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 

 

For the Quarterly Period Ended December 31, 2020

 

 

 

or

 

 

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period

 

from____________________

to_________________________

Commission File Number: 0-261

 

 

ALICO, INC.

(Exact name of registrant as specified in its charter)

 

Florida

 

59-0906081

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer Identification No.)

10070 Daniels Interstate Court

 

 

 

 

Suite 100

Fort Myers

FL

 

33913

(Address of principal executive offices)

 

(Zip Code)

 

(239)

226-2000

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock

ALCO

Nasdaq Global Select Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):

 

Large Accelerated Filer

Accelerated Filer

Non-accelerated filer

Smaller Reporting Company

Emerging Growth Company

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  No

 

There were 7,513,413 shares of common stock outstanding at February 2, 2021.

 


 

 

ALICO, INC.

FORM 10-Q

For the three months ended December 31, 2020 and 2019

Table of Contents

 

Part I - FINANCIAL INFORMATION

 

Item 1. Condensed Consolidated Financial Statements

 

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

21

Item 3. Quantitative and Qualitative Disclosures About Market Risk

30

Item 4. Controls and Procedures

30

Part II - OTHER INFORMATION

31

Item 1. Legal Proceedings

31

Item 1A. Risk Factors

31

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

31

Item 3. Defaults Upon Senior Securities

31

Item 4. Mine Safety Disclosure

31

Item 5. Other Information

31

Item 6. Exhibits

32

Signatures

33

 

 


 

 

PART I

Item 1. Condensed Consolidated Financial Statements

 

Index to Condensed Consolidated Financial Statements

 

Condensed Consolidated Balance Sheets as of December 31, 2020 (Unaudited) and September 30, 2020

1

Condensed Consolidated Statements of Operations for the three months ended December 31, 2020 and 2019 (Unaudited)

2

Condensed Consolidated Statements of Changes in Equity for the three months ended December 31, 2020 and 2019 (Unaudited)

3

Condensed Consolidated Statements of Cash Flows for the three months ended December 31, 2020 and 2019 (Unaudited)

4

Notes to Condensed Consolidated Financial Statements (Unaudited)

5

 

 

 


 

 

ALICO, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share amounts)

 

 

 

December 31,

 

 

September 30,

 

 

 

2020

 

 

2020

 

 

 

(Unaudited)

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

2,601

 

 

$

3,163

 

Accounts receivable, net

 

 

5,598

 

 

 

4,347

 

Inventories

 

 

46,430

 

 

 

40,855

 

Income tax receivable

 

 

 

 

781

 

Assets held for sale

 

 

1,410

 

 

 

1,366

 

Prepaid expenses and other current assets

 

 

1,755

 

 

 

1,387

 

Total current assets

 

 

57,794

 

 

 

51,899

 

 

 

 

 

 

 

 

 

 

Restricted cash

 

 

 

 

 

16,524

 

Property and equipment, net

 

 

367,221

 

 

 

350,061

 

Goodwill

 

 

2,246

 

 

 

2,246

 

Other non-current assets

 

 

2,921

 

 

 

3,207

 

Total assets

 

$

430,182

 

 

$

423,937

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

1,950

 

 

$

3,533

 

Accrued liabilities

 

 

5,473

 

 

 

7,095

 

Long-term debt, current portion

 

 

9,090

 

 

 

9,145

 

Income taxes payable

 

 

469

 

 

 

 

Other current liabilities

 

 

1,031

 

 

 

1,385

 

Total current liabilities

 

 

18,013

 

 

 

21,158

 

 

 

 

 

 

 

 

 

 

Long-term debt:

 

 

 

 

 

 

 

 

Principal amount, net of current portion

 

 

136,472

 

 

 

139,106

 

Less: deferred financing costs, net

 

 

(1,109

)

 

 

(1,151

)

Long-term debt less current portion and deferred financing costs, net

 

 

135,363

 

 

 

137,955

 

Lines of credit

 

 

12,204

 

 

 

2,942

 

Deferred income tax liabilities, net

 

 

39,728

 

 

 

39,728

 

Other liabilities

 

 

332

 

 

 

372

 

Total liabilities

 

 

205,640

 

 

 

202,155

 

Commitments and Contingencies (Note 12)

 

 

 

 

 

 

 

 

Stockholders' equity:

 

 

 

 

 

 

 

 

Preferred stock, no par value, 1,000,000 shares authorized; none issued

 

 

 

 

 

 

Common stock, $1.00 par value, 15,000,000 shares authorized; 8,416,145 shares issued and 7,506,160 and 7,492,524 shares outstanding at December 31, 2020 and September 30, 2020, respectively

 

 

8,416

 

 

 

8,416

 

Additional paid in capital

 

 

19,634

 

 

 

19,685

 

Treasury stock, at cost, 909,985 and 923,621 shares held at December 31, 2020 and September 30, 2020, respectively

 

 

(30,421

)

 

 

(30,779

)

Retained earnings

 

 

221,513

 

 

 

219,019

 

Total Alico stockholders' equity

 

 

219,142

 

 

 

216,341

 

Noncontrolling interest

 

 

5,400

 

 

 

5,441

 

Total stockholders' equity

 

 

224,542

 

 

 

221,782

 

Total liabilities and stockholders' equity

 

$

430,182

 

 

$

423,937

 

See accompanying notes to the condensed consolidated financial statements.

1


 

ALICO, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(in thousands, except per share amounts)

 

 

 

Three Months Ended

December 31,

 

 

 

2020

 

 

2019

 

Operating revenues:

 

 

 

 

 

 

 

 

Alico Citrus

 

$

12,926

 

 

$

10,175

 

Land Management and Other Operations

 

 

806

 

 

 

830

 

Total operating revenues

 

 

13,732

 

 

 

11,005

 

Operating expenses:

 

 

 

 

 

 

 

 

Alico Citrus

 

 

8,147

 

 

 

4,840

 

Land Management and Other Operations

 

188

 

 

 

551

 

Total operating expenses

 

 

8,335

 

 

 

5,391

 

Gross profit

 

 

5,397

 

 

 

5,614

 

General and administrative expenses

 

 

2,528

 

 

 

2,760

 

Income from operations

 

 

2,869

 

 

 

2,854

 

Other income (expense), net:

 

 

 

 

 

 

 

 

Interest expense

 

 

(1,189

)

 

 

(1,544

)

Gain on sale of real estate, property and equipment and assets held for sale

 

 

3,364

 

 

 

25

 

Other income (expense)

 

 

10

 

 

 

(76

)

Total other income (expense), net

 

 

2,185

 

 

 

(1,595

)

Income before income taxes

 

 

5,054

 

 

 

1,259

 

Income tax provision

 

 

1,250

 

 

 

361

 

Net income

 

 

3,804

 

 

 

898

 

Net loss (income) attributable to noncontrolling interests

 

 

41

 

 

 

(107

)

Net income attributable to Alico, Inc. common stockholders

 

$

3,845

 

 

$

791

 

Per share information attributable to Alico, Inc. common stockholders:

 

 

 

 

 

 

 

 

Earnings per common share:

 

 

 

 

 

 

 

 

Basic

 

$

0.51

 

 

$

0.11

 

Diluted

 

$

0.51

 

 

$

0.11

 

Weighted-average number of common shares outstanding:

 

 

 

 

 

 

 

 

Basic

 

 

7,503

 

 

 

7,477

 

Diluted

 

 

7,503

 

 

 

7,491

 

 

 

 

 

 

 

 

 

 

Cash dividends declared per common share

 

$

0.18

 

 

$

0.09

 

 

See accompanying notes to the condensed consolidated financial statements.

2


 

ALICO, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)

(in thousands)

 

For the Three Months Ended December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

 

 

 

 

Total

 

 

Non-

 

 

 

 

 

 

 

Common stock

 

 

Paid In

 

 

Treasury

 

 

Retained

 

 

Alico, Inc.

 

 

controlling

 

 

Total

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Stock

 

 

Earnings

 

 

Equity

 

 

Interest

 

 

Equity

 

Balance at September 30, 2020

 

 

8,416

 

 

$

8,416

 

 

$

19,685

 

 

$

(30,779

)

 

$

219,019

 

 

$

216,341

 

 

$

5,441

 

 

$

221,782

 

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,845

 

 

 

3,845

 

 

 

(41

)

 

 

3,804

 

Dividends ($0.18/share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,351

)

 

 

(1,351

)

 

 

 

 

 

(1,351

)

Stock-based compensation:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Directors

 

 

 

 

 

 

 

 

20

 

 

 

202

 

 

 

 

 

 

222

 

 

 

 

 

 

222

 

Executives and Managers

 

 

 

 

 

 

 

 

(71

)

 

 

156

 

 

 

 

 

 

85

 

 

 

 

 

 

85

 

Balance at December 31, 2020

 

 

8,416

 

 

$

8,416

 

 

$

19,634

 

 

$

(30,421

)

 

$

221,513

 

 

$

219,142

 

 

$

5,400

 

 

$

224,542

 

 

 

For the Three Months Ended December 31, 2019

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

 

 

 

 

Total

 

 

Non-

 

 

 

 

 

 

 

Common stock

 

 

Paid In

 

 

Treasury

 

 

Retained

 

 

Alico, Inc.

 

 

controlling

 

 

Total

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Stock

 

 

Earnings

 

 

Equity

 

 

Interest

 

 

Equity

 

Balance at September 30, 2019

 

 

8,416

 

 

$

8,416

 

 

$

19,781

 

 

$

(31,943

)

 

$

198,049

 

 

$

194,303

 

 

$

5,095

 

 

$

199,398

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

791

 

 

 

791

 

 

 

107

 

 

 

898

 

Dividends ($0.09/share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(671

)

 

 

(671

)

 

 

 

 

 

(671

)

Treasure stock purchases

 

 

 

 

 

 

 

 

 

 

 

(238

)

 

 

 

 

 

(238

)

 

 

 

 

 

(238

)

Stock-based compensation:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Directors

 

 

 

 

 

 

 

 

(32

)

 

 

225

 

 

 

 

 

 

193

 

 

 

 

 

 

193

 

Executives and Managers

 

 

 

 

 

 

 

 

108

 

 

 

 

 

 

 

 

 

108

 

 

 

 

 

 

108

 

Balance at December 31, 2019

 

 

8,416

 

 

$

8,416

 

 

$

19,857

 

 

$

(31,956

)

 

$

198,169

 

 

$

194,486

 

 

$

5,202

 

 

$

199,688

 

 

 

See accompanying notes to the condensed consolidated financial statements.

3


 

ALICO, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(in thousands)

 

 

 

Three Months Ended

December 31,

 

 

 

2020

 

 

2019

 

Net cash used in operating activities:

 

 

 

 

 

 

 

 

Net income

 

$

3,804

 

 

$

898

 

Adjustments to reconcile net income to net cash used in operating activities:

 

 

 

 

 

 

 

 

Depreciation, depletion, and amortization

 

 

3,851

 

 

 

3,609

 

Gain on sale of real estate, property and equipment and assets held for sale

 

 

(3,364

)

 

 

(25

)

Loss on disposal of long-lived assets

 

 

443

 

 

 

88

 

Impairment of right-of-use asset

 

 

 

 

87

 

Stock-based compensation expense

 

 

307

 

 

 

301

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(1,251

)

 

 

(1,139

)

Inventories

 

 

(5,575

)

 

 

(3,145

)

Prepaid expenses

 

 

(432

)

 

 

(477

)

Income tax receivable

 

 

781

 

 

 

 

Other assets

 

 

134

 

 

 

(457

)

Accounts payable and accrued liabilities

 

 

(3,882

)

 

 

(6,213

)

Income taxes payable

 

 

469

 

 

 

361

 

Other liabilities

 

 

(394

)

 

 

69

 

Net cash used in operating activities

 

 

(5,109

)

 

 

(6,043

)

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Purchases of property and equipment

 

 

(5,062

)

 

 

(3,541

)

Acquisition of citrus grove

 

 

(16,450

)

 

 

 

Net proceeds from sale of real estate, property and equipment and assets held for sale

 

 

3,425

 

 

 

42

 

Change in deposits on purchase of citrus trees

 

 

64

 

 

 

(194

)

Advances on notes receivables, net

 

 

122

 

 

 

4

 

Other

 

 

25

 

 

 

 

Net cash used in investing activities

 

 

(17,876

)

 

 

(3,689

)

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Repayments on revolving lines of credit

 

 

(14,187

)

 

 

 

Borrowings on revolving lines of credit

 

 

23,449

 

 

 

 

Principal payments on term loans

 

 

(2,689

)

 

 

(7,132

)

Treasury stock purchases

 

 

 

 

(238

)

Dividends paid

 

 

(674

)

 

 

(448

)

Deferred financing costs

 

 

 

 

(23

)

Net cash provided by (used in) financing activities

 

 

5,899

 

 

 

(7,841

)

 

 

 

 

 

 

 

 

 

Net decrease in cash and cash equivalents and restricted cash

 

 

(17,086

)

 

 

(17,573

)

Cash and cash equivalents and restricted cash at beginning of the period

 

 

19,687

 

 

 

23,838

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents and restricted cash at end of the period

 

$

2,601

 

 

$

6,265

 

 

See accompanying notes to the condensed consolidated financial statements.

4


 

ALICO, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

Note 1. Description of Business and Basis of Presentation

Description of Business

Alico, Inc., together with its subsidiaries (collectively, “Alico”, the “Company", "we", "us" or "our”), is a Florida agribusiness and land management company owning approximately 103,000 acres of land throughout Florida, holding mineral rights on approximately 90,000  of those owned acres. The Company manages its land based upon its primary usage, and reviews its performance based upon two primary classifications: (i) Alico Citrus and (ii) Land Management and Other Operations. Financial results are presented based upon these two business segments.

Basis of Presentation

The Company has prepared the accompanying financial statements on a condensed consolidated basis. These accompanying unaudited condensed consolidated interim financial statements, which are referred to herein as the “Financial Statements", have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to Article 10-01 of Regulation S-X of the U.S. Securities and Exchange Commission ("SEC") for interim financial information. These Financial Statements do not include all of the disclosures required for complete annual financial statements and, accordingly, certain information, footnotes and disclosures normally included in annual financial statements, prepared in accordance with U.S. GAAP, have been condensed or omitted in accordance with SEC rules and regulations. Accordingly, the Financial Statements should be read in conjunction with the Company's audited Consolidated Financial Statements and Notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2020, as filed with the SEC on December 8, 2020.

The Financial Statements presented in this Quarterly Report on Form 10-Q are unaudited. However, in the opinion of management, such Financial Statements include all adjustments, consisting solely of normal recurring adjustments, necessary to present fairly the financial position, results of operations and cash flows for the periods presented in conformity with U.S. GAAP applicable to interim periods.

Operating results for the interim periods presented are not necessarily indicative of the results that may be expected for the current fiscal year ending September 30, 2021.

Segments

Operating segments are defined in the criteria established under the Financial Accounting Standards Board - Accounting Standards Codification (“FASB ASC”) Topic 280 as components of public entities that engage in business activities from which they may earn revenues and incur expenses for which separate financial information is available and which is evaluated regularly by the Company’s chief operating decision maker (“CODM”) in deciding how to assess performance and allocate resources. The Company’s CODM assesses performance and allocates resources based on two operating segments: (i) Alico Citrus and (ii) Land Management and Other Operations.

Principles of Consolidation

The Financial Statements include the accounts of Alico and the accounts of all the subsidiaries in which a controlling interest is held by the Company. Under U.S. GAAP, consolidation is generally required for investments of more than 50% of the outstanding voting stock of an investee, except when control is not held by the majority owner. The Company’s subsidiaries include: Alico Land Development, Inc., Alico-Agri, Ltd., Alico Plant World, LLC, Alico Fruit Company, LLC, Alico Citrus Nursery, LLC, Alico Chemical Sales, LLC, 734 Citrus Holdings, LLC and subsidiaries, Alico Skink Mitigation, LLC and Citree Holdings 1, LLC (“Citree”). The Company considers the criteria established under FASB ASC Topic 810, “Consolidations” in its consolidation process. All significant intercompany balances and transactions have been eliminated in consolidation.

5


 

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities as of the date of the accompanying Financial Statements, the disclosure of contingent assets and liabilities in the Financial Statements and the accompanying Notes, and the reported amounts of revenues and expenses and cash flows during the periods presented. Actual results could differ from those estimates. The Company evaluates estimates on an ongoing basis. The estimates are based on current and expected economic conditions, historical experience, the experience and judgment of the Company’s management and various other specific assumptions that the Company believes to be reasonable.

Restricted Cash

Restricted cash is comprised of cash receipts from the sale of property which was being held specifically for the purpose of deferring a tax impact on the gain on sale of the property.

In September 2020, the Company sold certain sections of the West Ranch, from which a portion of the net cash proceeds amounting to $16,524,000 were being held by a qualified intermediary in anticipation of purchasing a like-kind asset and in order to defer a portion of the gain on sale of the ranch land. Such funds were included in restricted cash at September 30, 2020. In October 2020, the Company closed on a purchase of a like-kind asset and used all of these net cash proceeds which were being held by the intermediary.

Revenue Recognition

Revenues are derived from the sale of processed fruit, fresh fruit, other citrus revenue, leasing revenue and other resource revenues. The majority of the revenue is generated from the sale of citrus fruit to processing facilities, fresh fruit sales and grove management services. The Company recognizes revenue in the amount it expects it will be entitled to be paid, determined when control of the products or services is transferred to its customers, which occurs upon delivery of and acceptance of the fruit by the customer and when the Company has a right to payment.

For the sale of fruit, the Company has identified one performance obligation, which is the delivery of fruit to the processing facility of the customer (or harvesting of the citrus in the case of fresh fruit) for each separate variety of fruit identified in the respective contract with the respective customer. The Company initially recognizes revenue in an amount which is estimated based on contractual and market prices, including if such market price falls within the range (known as “floor” and “ceiling” prices) identified in the specific respective contracts. Additionally, the Company also has a contractual agreement whereby revenue is determined based on applying a cost-plus structure methodology. As such, since all of these contracts contain elements of variable consideration, the Company recognizes this variable consideration by using the expected value method. On a quarterly basis, management reviews the reasonableness of the revenues accrued based on buyers’ and processors’ advances to growers, cash and futures markets and experience in the industry. Adjustments are made throughout the year to these estimates as more current relevant industry information becomes available. Differences between the estimates and the final realization of revenues at the close of the harvesting season can result in either an increase or decrease to reported revenues.

Receivables under contracts, whereby pricing is based on contractual and market prices, are primarily paid at the floor amount and are collected within seven days after the harvest week. Any adjustments to pricing as a result of changes in market prices are collected or paid thirty to sixty days after final market pricing is published. Receivables under contracts, whereby pricing is based off a cost-plus structure methodology, are paid at the final prior year rate. Any adjustments to pricing as a result of the cost-plus calculation are collected or paid upon finalization of the calculation and agreement by both parties. As of December 31, 2020, and September 30, 2020, the Company had total receivables relating to sales of citrus of approximately $4,328,000 and $584,000, respectively, recorded in Accounts Receivable, net, in the Condensed Consolidated Balance Sheets.

6


 

For grove management services, the Company has identified one performance obligation, which is the management of the third party’s groves. Grove management services include caretaking of the citrus groves, harvesting and hauling of citrus, management and coordination of citrus sales and other related activities. The Company is reimbursed for expenses incurred in the execution of its management duties and the Company receives a per acre management fee. The Company recognizes operating revenue, including a management fee, and corresponding operating expenses when such grove management services are rendered and consumed.

Disaggregated Revenue

Revenues disaggregated by significant products and services for the three months ended December 31, 2020 and 2019 are as follows:

 

(in thousands)

 

 

 

 

 

 

 

 

 

 

Three Months Ended

December 31,

 

 

 

2020

 

 

2019

 

Alico Citrus

 

 

 

 

 

 

 

 

Early and Mid-Season

 

$

9,315

 

 

$

9,066

 

Fresh Fruit

 

 

409

 

 

 

735

 

Grove Management Services

 

 

3,092

 

 

 

305

 

Other

 

 

110

 

 

 

69

 

Total

 

$

12,926

 

 

$

10,175

 

 

 

 

 

 

 

 

 

 

Land Management and Other Operations

 

 

 

 

 

 

 

 

Land and Other Leasing

 

$

727

 

 

$

663

 

Other

 

 

79

 

 

 

167

 

Total

 

$

806

 

 

$

830

 

 

 

 

 

 

 

 

 

 

Total Revenues

 

$

13,732

 

 

$

11,005

 

 

Noncontrolling Interest in Consolidated Subsidiary

The Financial Statements include all assets and liabilities of the less-than-100%-owned subsidiary the Company controls, Citree. Accordingly, the Company has recorded a noncontrolling interest in the equity of such entity. Citree had a net loss of $82,500 for the three months ended December 31, 2020 and net income of $218,414 for the three months ended December 31, 2019, of which 51% is attributable to the Company. The net income for the three months ended December 31, 2019, was the result of reimbursements received under the federal relief program relating to Hurricane Irma, aggregating approximately $330,000.

Recent Accounting Pronouncements

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides temporary optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships and other transactions affected by reference rate reform. The Company’s floating rate notes and variable funding notes bear interest at fluctuating interest rates based on LIBOR. If LIBOR ceases to exist, the Company may need to renegotiate its loan agreements and the Company cannot predict what alternative index would be negotiated with its lenders. ASU 2020-04 is currently effective and upon adoption may be applied prospectively to contract modifications made on or before December 31, 2022. The Company is currently assessing the impact of adopting this standard and the impact on its condensed consolidated financial statements.

7


 

The Company has reviewed other recently issued accounting standards which have not yet been adopted in order to determine their potential effect, if any, on the results of operations or financial condition. Based on the review of these other recently issued standards, the Company does not currently believe that any of those accounting pronouncements will have a significant effect on its current or future financial position, results of operations, cash flows or disclosures.

Recently Adopted Accounting Pronouncements

In January 2017, the FASB issued Accounting Standards Update (“ASU”) 2017-04, “Intangibles-Goodwill and Other” (Topic 350), which simplifies the accounting for goodwill impairment. The updated guidance eliminates Step 2 of the impairment test, which requires entities to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value, determined in Step 1. The Company adopted ASU 2017-04 effective October 1, 2020, using the prospective approach, and will apply this standard in future impairment tests.

In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurements” (ASU 2018-13), which aims to improve the overall usefulness of disclosures to financial statement users and reduce unnecessary costs to companies when preparing fair value measurement disclosures. ASU 2018-13 is effective for annual and interim periods in the fiscal years beginning after December 15, 2019. Retrospective adoption is required, except for certain disclosures, which will be required to be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. The Company adopted ASU 2018-13 effective October 1, 2020, and the adoption of this standard did not have a material impact on the Company’s condensed consolidated financial statements.

In November 2018, the FASB issued ASU 2018-19, “Codification Improvements to Topic 326, Financial Instruments-Credit Losses.” ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of Subtopic 326-20. Instead, impairment of receivables arising from operating leases should be accounted for in accordance with Leases (Topic 842). The Company adopted ASU 2018-19 effective October 1, 2020, and the adoption of this standard did not have a material impact on the Company’s condensed consolidated financial statements.

The COVID-19 Pandemic

On March 11, 2020, the World Health Organization declared the current novel coronavirus outbreak (“COVID-19”) to be a global pandemic. In response to this declaration and the rapid spread of COVID-19 within the United States, federal, state and local governments throughout the country imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures have had a significant adverse impact upon many sectors of the economy, including certain agriculture businesses. To date, the Company has experienced no material adverse impact from this pandemic.

Reclassifications

Certain prior year amounts have been reclassified in the accompanying Financial Statements for consistent presentation to the current period. These reclassifications had no impact on net income, equity, cash flows or working capital as previously reported.

Seasonality

The Company is primarily engaged in the production of fruit for sale to citrus markets, which is of a seasonal nature, and subject to the influence of natural phenomena and wide price fluctuations. Historically, the second and third quarters of Alico's fiscal year produce the majority of the Company's annual revenue. Working capital requirements are typically greater in the first and fourth quarters of the fiscal year, coinciding with harvesting cycles. Because of the seasonality of the business, results for any quarter are not necessarily indicative of the results that may be achieved for the full fiscal year.

8


 

Note 2. Inventories

Inventories consist of the following at December 31, 2020 and September 30, 2020:

 

(in thousands)

 

December 31,

 

 

September 30,

 

 

 

2020

 

 

2020

 

Unharvested fruit crop on the trees

 

$

45,925

 

 

$

40,265

 

Other

 

 

505

 

 

 

590

 

Total inventories

 

$

46,430

 

 

$

40,855

 

 

The Company records its inventory at the lower of cost or net realizable value. For the three months ended December 31, 2020 and the year ended September 30, 2019, the Company did not record any adjustments to reduce inventory to net realizable value. 

The Company was eligible for Hurricane Irma federal relief programs for block grants that were being administered through the State of Florida. During the fiscal years ended September 30, 2020 and 2019, the Company received approximately $4,629,000, of which approximately $4,466,000 was received during the quarter ended December 31, 2019, and $15,597,000 under the Florida Citrus Recovery Block Grant (“CRBG”) program. These federal relief proceeds represented Part 1 and Part 2 reimbursement under the three-part program. In the quarter ended December 31, 2020, the Company received approximately $4,136,000, representing reimbursement under Part 3 of the program. These federal relief proceeds are included as a reduction to operating expenses in the Condensed Consolidated Statements of Operations.

Note 3. Assets Held for Sale

In accordance with its strategy to dispose of non-core and under-performing assets, the following assets have been classified as assets held for sale at December 31, 2020 and September 30, 2020:

 

(in thousands)

 

Carrying Value

 

 

 

December 31,

 

 

September 30,

 

 

 

2020

 

 

2020

 

East and West Ranch

 

$

1,410

 

 

$

1,366

 

Total Assets Held for Sale

 

$

1,410

 

 

$

1,366

 

 

On December 18, 2020, the Company sold approximately 600 acres of the East Ranch for approximately $2,630,000 and recognized a gain of approximately $2,550,000. Additionally, the Company sold several smaller parcels of the East Ranch during the quarter ended December 31, 2020, which generated a gain of approximately $814,000.

 

On September 10, 2020, the State of Florida purchased, under the Florida Forever program, approximately 10,700 acres of the Alico Ranch for approximately $28,500,000 pursuant to an option agreement entered into between the State of Florida and the Company. The Company recognized a gain of approximately $27,470,000. The Company subsequently used a portion of the net cash proceeds to purchase a like-kind asset in October 2020, which allowed the Company to defer a portion of the tax impact of the gain on sale of the ranch land (see Note 4. Property and Equipment, Net).

 

On March 27, 2020, the Company sold certain sections at the East Ranch for approximately $2,980,000 and realized a gain of approximately $2,748,000. The Company subsequently used substantially all of the net cash proceeds to purchase a like-kind asset in May 2020, which has allowed the Company to defer substantially all of the tax impact of the gain on sale of the ranch land.

9


 

Note 4. Property and Equipment, Net

Property and equipment, net consists of the following at December 31, 2020 and September 30, 2020:

 

(in thousands)

 

December 31,

 

 

September 30,

 

 

 

2020

 

 

2020

 

Citrus trees

 

$

307,384

 

 

$

296,012

 

Equipment and other facilities

 

 

56,617

 

 

 

55,593

 

Buildings and improvements

 

 

8,110

 

 

 

8,128

 

Total depreciable properties

 

 

372,111

 

 

 

359,733

 

Less: accumulated depreciation and depletion

 

 

(118,795

)

 

 

(115,440

)

Net depreciable properties

 

 

253,316

 

 

 

244,293

 

Land and land improvements

 

 

113,905

 

 

 

105,768

 

Property and equipment, net

 

$

367,221

 

 

$

350,061

 

 

For the three months ended December 31, 2020 and fiscal year ended September 30, 2020, the Company did not record any impairments.

 

On October 30, 2020, the Company purchased approximately 3,280 gross acres located in Hendry County for a purchase price of approximately $16,450,000.

 

On June 1, 2020, the Company sold approximately 30 ranch acres to an employee for approximately $122,000 and recognized a gain of approximately $83,000.

 

On May 4, 2020, the Company purchased approximately 334 citrus acres for approximately $2,850,000. This acquisition complements the Company’s existing citrus acres as these acres are located adjacent to existing groves in the Frostproof area. Additionally, this purchase was part of a like-kind exchange transaction, which will allow the Company to defer taxes relating to the sale of certain sections of the East Ranch.

Note 5. Long-Term Debt and Lines of Credit

The following table summarizes long-term debt and related deferred financing costs, net of accumulated amortization at December 31, 2020 and September 30, 2020:

 

 

 

December 31, 2020

 

 

September 30, 2020

 

(in thousands)

 

Principal

 

 

Deferred

Financing

Costs, Net

 

 

Principal

 

 

Deferred

Financing

Costs, Net

 

Long-term debt, net of current portion:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Met Fixed-Rate Term Loans

 

$

81,875

 

 

$

596

 

 

$

83,438

 

 

$

621

 

Met Variable-Rate Term Loans

 

 

40,250

 

 

 

274

 

 

 

40,969

 

 

 

286

 

Met Citree Term Loan

 

 

4,450

 

 

 

35

 

 

 

4,512

 

 

 

36

 

Pru Loans A & B

 

 

14,807

 

 

 

203

 

 

 

15,097

 

 

 

207

 

Pru Loan E

 

 

4,180

 

 

 

1

 

 

 

4,235

 

 

 

1

 

 

 

 

145,562

 

 

 

1,109

 

 

 

148,251

 

 

 

1,151

 

Less current portion

 

 

9,090

 

 

 

 

 

 

9,145

 

 

 

 

Long-term debt

 

$

136,472

 

 

$

1,109

 

 

$

139,106

 

 

$

1,151

 

 

10


 

 

The following table summarizes lines of credit and related deferred financing costs, net of accumulated amortization at December 31, 2020 and September 30, 2020:

 

 

 

December 31, 2020

 

 

September 30, 2020

 

(in thousands)

 

Principal

 

 

Deferred

Financing

Costs, Net

 

 

Principal

 

 

Deferred

Financing

Costs, Net

 

Lines of Credit:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

RLOC

 

$

 

 

$

138

 

 

$

 

 

$

141

 

WCLC

 

 

12,204

 

 

 

 

 

 

2,942

 

 

 

 

Lines of Credit

 

$

12,204

 

 

$

138

 

 

$

2,942

 

 

$

141

 

 

Future maturities of long-term debt and lines of credit as of December 31, 2020 are as follows:

 

(in thousands)

 

 

 

 

 

 

December 31, 2020

 

Due within one year

 

$

9,090

 

Due between one and two years

 

 

10,535

 

Due between two and three years

 

 

22,739

 

Due between three and four years

 

 

10,535

 

Due between four and five years

 

 

10,535

 

Due beyond five years

 

 

94,332

 

 

 

 

 

 

Total future maturities

 

$

157,766

 

 

Interest costs expensed and capitalized were as follows:

 

(in thousands)

 

 

 

 

 

 

 

 

 

 

Three Months Ended

December 31,

 

 

 

2020

 

 

2019

 

Interest expense

 

$

1,189

 

 

$

1,544

 

Interest capitalized

 

 

312

 

 

 

269

 

Total

 

$

1,501

 

 

$

1,813

 

 

Debt

The Company's credit facilities consist of $125,000,000 in fixed interest rate term loans (“Met Fixed-Rate Term Loans”), $57,500,000 in variable interest rate term loans (“Met Variable-Rate Term Loans”), a $25,000,000 revolving line of credit (“RLOC”) with Metropolitan Life Insurance Company and New England Life Insurance Company (collectively “Met”), and a $70,000,000 working capital line of credit (“WCLC”) with Rabo Agrifinance, Inc. (“Rabo”).

The term loans and RLOC are secured by real property. The security for the term loans and RLOC consists of approximately 38,200 gross acres of citrus groves and 5,800 gross acres of ranch land. The WCLC is collateralized by the Company’s current assets and certain other personal property owned by the Company.

The term loans, collectively, are subject to quarterly principal payments of $2,281,250, and mature November 1, 2029. The Met Fixed-Rate Term Loans bear interest at 4.15% per annum, and the Met Variable-Rate Term Loans bear interest at a rate equal to 90-day LIBOR plus 165 basis points (the “LIBOR spread”). The LIBOR spread is subject to adjustment by Met beginning May 1, 2017 and is subject to further adjustment every two years thereafter until maturity. No adjustment was made at May 1, 2019. Interest on the term loans is payable quarterly. The interest rates on the Met Variable-Rate Term Loans were 1.86% per annum and 1.91% per annum as of December 31, 2020 and September 30, 2020, respectively.

11


 

The Company may prepay up to $8,750,000 of the Met Fixed-Rate Term Loan principal annually without penalty, and any such prepayments may be applied to reduce subsequent mandatory principal payments. The maximum annual prepayment was made for calendar year 2015. During the first and second quarter of fiscal year 2018, the Company elected not to make its principal payment and utilized a portion of its 2015 prepayment to satisfy its principal payment requirements for such quarters. At December 31, 2020, the Company had $5,625,000 remaining available to reduce future mandatory principal payments should the Company elect to do so. The Met Variable-Rate Term Loans may be prepaid without penalty.

The RLOC bears interest at a floating rate equal to 90-day LIBOR plus 165 basis points, payable quarterly. The LIBOR spread was adjusted by Met on May 1, 2017 and is subject to further adjustment every two years thereafter. No adjustment was made at May 1, 2019. In October 2019, the RLOC agreement was modified to extend the maturity to November 1, 2029. The RLOC is subject to an annual commitment fee of 25 basis points on the unused portion of the line of credit. The RLOC is available for funding general corporate needs. The variable interest rate was 1.86% and 1.91% per annum as of December 31, 2020 and September 30, 2020, respectively. Availability under the RLOC was $25,000,000 as of December 31, 2020 and September 30 2020, respectively.

The WCLC is a revolving credit facility and is available for funding working capital and general corporate requirements. The interest rate on the WCLC is based on the one month LIBOR, plus a spread, which is adjusted quarterly, based on the Company's debt service coverage ratio for the preceding quarter and can vary from 175 to 250 basis points. The rate is currently at LIBOR plus 175 basis points. The variable interest rate was 1.90% and 1.90% per annum as of December 31, 2020 and September 30, 2020, respectively. The WCLC agreement was amended on August 25, 2020, and the primary terms of the amendment were an extension of the maturity to November 1, 2023. There were no changes to the commitment amount or interest rate. The WCLC agreement provides for Rabo to issue up to $2,000,000 in letters of credit on the Company’s behalf. As of December 31, 2020, there was approximately $236,000 in outstanding letters of credit, which correspondingly reduced the Company's availability under the line of credit.

The WCLC is subject to a quarterly commitment fee on the daily unused availability under the line computed as the commitment amount less the aggregate of the outstanding loans and outstanding letters of credit. The commitment fee is adjusted quarterly based on Alico's debt service coverage ratio for the preceding quarter and can vary from a minimum of 20 basis points to a maximum of 30 basis points. Commitment fees to date have been charged at 20 basis points.

There was approximately $12,204,000 and $2,942,000 outstanding on the WCLC at December 31, 2020 and September 30, 2020, respectively.  Availability under the WCLC was approximately $57,560,000 and $66,659,000 as of December 31, 2020 and September 30, 2020, respectively.

In 2014, the Company capitalized approximately $2,834,000 of debt financing costs related to the refinancing and approximately $339,000 of costs related to the retired debt. Additionally, financing costs of approximately $23,000 were incurred in the fiscal year ended September 30, 2020 in connection with the letters of credit. All costs are included in deferred financing costs and being amortized to interest expense over the applicable terms of the obligations. The unamortized balance of deferred financing costs related to the financing above was approximately $1,008,000 and approximately $1,048,000 at December 31, 2020 and September 30, 2020, respectively.

These credit facilities noted above are subject to various covenants including the following financial covenants: (i) minimum debt service coverage ratio of 1.10 to 1.00, (ii) tangible net worth of at least $160,000,000 increased annually by 10% of consolidated net income for the preceding years, or approximately $169,730,000 for the year ended September 30, 2020, (iii) minimum current ratio of 1.50 to 1.00, (iv) debt to total assets ratio not greater than .625 to 1.00, and, (v) solely in the case of the WCLC, a limit on capital expenditures of $30,000,000 per fiscal year. As of December 31, 2020, the Company was in compliance with all of the financial covenants.

Credit facilities also include a Met Life term loan collateralized by 1,200 gross acres of citrus grove owned by Citree ("Met Citree Loan"). This is a $5,000,000 credit facility that bears interest at a fixed rate of 5.28% per annum. Principal and interest payments are made on a quarterly basis. At December 31, 2020 and September 30, 2020, there was an outstanding balance of $4,450,000 and $4,512,000, respectively. The loan matures in February 2029. The unamortized balance of deferred financing costs related to this loan was approximately $35,000 and $36,000 at December 31, 2020 and September 30, 2020, respectively.

12


 

Transition from LIBOR

The Company is currently evaluating the impact of the transition from LIBOR as an interest rate benchmark to other potential alternative reference rates. Currently, the Company has debt instruments in place that reference LIBOR-based rates. The transition from LIBOR is estimated to take place in 2022 and management will continue to actively assess the related opportunities and risks involved in this transition.

Silver Nip Citrus Debt

There are two fixed-rate term loans, with an original combined balance of $27,550,000, bearing interest at 5.35% per annum (“Pru Loans A & B”). Principal of $290,000 is payable quarterly, together with accrued interest. On February 15, 2015, 734 Citrus Holdings, LLC d/b/a Silver Nip Citrus (“Silver Nip Citrus”) made a prepayment of $750,000. In addition, the Company made prepayments of approximately $4,453,000 in the second fiscal quarter of 2018 with proceeds from the sale of certain properties, which were collateralized under these loans. The Company may prepay up to $5,000,000 of principal without penalty.  As such, the Company exceeded the allowed $5,000,000 prepayment by approximately $203,000 and was required to make a premium payment of approximately $22,000. The loans are collateralized by approximately 5,700 acres of citrus groves in Collier, Hardee, Highlands and Polk Counties, Florida and mature on June 1, 2029 and June 1, 2033, respectively.

Silver Nip Citrus entered into two additional fixed-rate term loans with Prudential to finance the acquisition of a 1,500 acre citrus grove on September 4, 2014. Each loan (“Pru Loan E” and “Pru Loan F”) was in the original amount of $5,500,000 with principal of $55,000 per loan being payable quarterly, together with accrued interest.  In November 2019, the Company prepaid Pru Loan F in full in the amount of $4,455,000. As a result of this prepayment, the Company’s required annual principal payments on its Pru Loans was reduced by $220,000 per annum. Pru Loan E, which matures September 1, 2021, bears interest at 3.85% per annum. The interest rate on Pru Loan E is subject to adjustment on September 1, 2019 and every year thereafter until maturity. No adjustment was made at September 1, 2019. This loan is collateralized by approximately 1,500 gross acres of citrus groves in Charlotte County, Florida.

 

The Silver Nip Citrus credit agreements are subject to a financial covenant whereby the consolidated current ratio requirement is 1.00 to 1.00. Silver Nip Citrus was in compliance with the current ratio covenant as of December 31, 2020.

The unamortized balance of deferred financing costs related to the Silver Nip Citrus debt was approximately $204,000 and $208,000 at December 31, 2020 and September 30, 2020, respectively.

Note 6. Accrued Liabilities

Accrued liabilities consist of the following at December 31, 2020 and September 30, 2020:

 

(in thousands)

 

December 31,

 

 

September 30,

 

 

 

2020

 

 

2020

 

Ad valorem taxes

 

$

 

 

$

2,057

 

Accrued interest

 

 

992

 

 

 

1,020

 

Accrued employee wages and benefits

 

 

945

 

 

 

2,214

 

Accrued harvest and haul

 

 

671

 

 

 

 

Accrued dividends

 

 

1,351

 

 

 

674

 

Consulting and separation charges

 

 

46

 

 

 

146

 

Accrued insurance

 

 

1,096

 

 

 

636

 

Other accrued liabilities

 

 

372

 

 

 

348

 

Total accrued liabilities

 

$

5,473

 

 

$

7,095

 

 

13


 

 

Note 7. Income Taxes

In October 2019, the Internal Revenue Service concluded its audit of the September 30, 2015 tax year with no changes. The Federal and state filings remain subject to examination by tax authorities for tax periods ending after September 30, 2015. 

On March 27, 2020, President Trump signed into law the Coronavirus Aid, Relief, and Economic Security Act (H.R. 748) (the “CARES Act”). Among the changes to the U.S. federal income tax rules, the CARES Act restored net operating loss carryback rules that were eliminated by the 2017 Tax Cuts and Jobs Act, modified the limit on the deduction for net interest expense, and accelerated the timeframe for refunds of AMT credit carryovers. From a federal tax reporting standpoint, the Company anticipates a federal tax net operating loss (“NOL”) for the fiscal year ending September 30, 2020 and plans to carry back the NOL pursuant to the provisions of the CARES Act. As a result of the federal tax NOL carryback, the Company estimates a cash tax benefit of approximately $605,000, with an income statement benefit of approximately $82,000.

Note 8. Earnings Per Common Share

 

Basic earnings per share for Alico's common stock is calculated by dividing net income attributable to Alico, Inc. common stockholders by the weighted average number of shares of common stock outstanding for the period.  Diluted earnings per common share is similarly calculated, except that the calculation includes the dilutive effect of the assumed issuance of common shares issuable under equity-based compensation plans in accordance with the treasury stock method, except where the inclusion of such common shares would have an anti-dilutive impact.

 

 

For the three months ended December 31, 2020 and 2019, basic and diluted earnings per common share were as follows:

 

(in thousands except per share amounts)

 

Three Months Ended

December 31,

 

 

 

2020

 

 

2019

 

Net income attributable to Alico, Inc. common stockholders

 

$

3,845

 

 

$

791

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding - basic

 

 

7,503

 

 

 

7,477

 

Dilutive effect of equity-based awards

 

 

 

 

 

14

 

Weighted average number of common shares outstanding - diluted

 

 

7,503

 

 

 

7,491

 

 

 

 

 

 

 

 

 

 

Net income per common share attributable to Alico, Inc. common stockholders:

 

 

 

 

 

 

 

 

Basic

 

$

0.51

 

 

$

0.11

 

Diluted

 

$

0.51

 

 

$

0.11

 

 

For the three months ended December 31, 2020, the equity awards had no dilutive or anti-dilutive impact on the earnings per common share. For the three months ended December 31, 2019, there were no anti-dilutive equity awards excluded from the calculation of diluted earnings per common share.

Note 9. Segment Information

Segments

Operating segments are defined in the criteria established under the FASB ASC Topic 280 as components of public entities that engage in business activities from which they may earn revenues and incur expenses for which separate financial information is available and which is evaluated regularly by the Company’s CODM in deciding how to assess performance and allocate resources. The Company’s CODM assesses performance and allocates resources based on two operating segments: Alico Citrus and Land Management and Other Operations.

14


 

Total revenues represent sales to unaffiliated customers, as reported in the Condensed Consolidated Statements of Operations. Goods and services produced by these segments are sold to wholesalers and processors in the United States who prepare the products for consumption. The Company evaluates the segments’ performance based on direct margins (gross profit) from operations before general and administrative expenses, interest expense, other income (expense) and income taxes, not including nonrecurring gains and losses.

 

Information by operating segment is as follows:

 

(in thousands)

 

Three Months Ended

December 31,

 

 

 

2020

 

 

2019

 

Revenues:

 

 

 

 

 

 

 

 

Alico Citrus

 

$

12,926

 

 

$

10,175

 

Land Management and Other Operations

 

 

806

 

 

 

830

 

Total revenues

 

 

13,732

 

 

 

11,005

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

Alico Citrus

 

 

8,147

 

 

 

4,840

 

Land Management and Other Operations

 

 

188

 

 

 

551

 

Total operating expenses

 

 

8,335

 

 

 

5,391

 

 

 

 

 

 

 

 

 

 

Gross profit:

 

 

 

 

 

 

 

 

Alico Citrus

 

 

4,779

 

 

 

5,335

 

Land Management and Other Operations

 

 

618

 

 

 

279

 

Total gross profit

 

$

5,397

 

 

$

5,614

 

 

 

 

 

 

 

 

 

 

Depreciation, depletion and amortization:

 

 

 

 

 

 

 

 

Alico Citrus

 

$

3,689

 

 

$

3,437

 

Land Management and Other Operations

 

 

38

 

 

 

46

 

Other Depreciation, Depletion and Amortization

 

 

124

 

 

 

126

 

Total depreciation, depletion, and amortization

 

$

3,851

 

 

$

3,609

 

 

(in thousands)

 

December 31,

 

 

September 30,

 

 

 

2020

 

 

2020

 

Assets:

 

 

 

 

 

 

 

 

Alico Citrus

 

$

413,751

 

 

$

406,763

 

Land Management and Other Operations

 

 

14,745

 

 

 

15,367

 

Other Corporate Assets

 

 

1,686

 

 

 

1,807

 

Total Assets

 

$

430,182

 

 

$

423,937

 

 

Note 10. Leases

In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).” This guidance requires entities that sign leases as a lessee to recognize right-of-use assets and lease liabilities for those leases classified as operating leases under previous U.S. GAAP. The accounting applied by a lessor is largely unchanged from that applied under previous U.S. GAAP. The Company adopted ASU 2016-02 on October 1, 2019.

The Company determines whether an arrangement is a lease at inception. The Company’s leases consist of operating lease arrangements for certain office space and IT facilities. When these lease arrangements include lease and non-lease components, the Company accounts for lease components and non-lease components (e.g., common area maintenance) separately based on their relative standalone prices.

15


 

Any lease arrangements with an initial term of 12 months or less are not recorded on the Company’s Condensed Consolidated Balance Sheets, and it recognizes lease cost for these lease arrangements on a straight-line basis over the lease term. Many lease arrangements provide the options to exercise one or more renewal terms or to terminate the lease arrangement. The Company includes these options when it will be reasonably certain to exercise them in the lease term used to establish the right-of-use assets and lease liabilities. Generally, lease agreements do not include an option to purchase the leased asset, residual value guarantees or material restrictive covenants.

As most of our lease arrangements do not provide an implicit interest rate, the Company applies an incremental borrowing rate based on the information available at the commencement date of the lease arrangement to determine the present value of lease payments.

No lease costs associated with finance leases and sale-leaseback transactions occurred and our lease income associated with lessor and sublease arrangements are not material to our Condensed Consolidated Financial Statements.

 

Our operating leases cost components are reported in our Condensed Consolidated Statements of Operations as follows:

 

(in thousands)

 

Three Months Ended December 31,

 

Operating lease components

 

2020

 

 

2019

 

Operating leases costs recorded in General and Administrative expenses

 

$

132

 

 

$

52

 

Operating lease right-of-use asset impairment recorded in Other expenses

 

$

 

 

$

87

 

 

The weighted-average remaining lease term and weighted-average discount rate for our operating leases are as follows:

 

 

 

 

 

December 31, 2020

 

Weighted-average remaining lease term

 

 

 

1.36 years

 

Weighted-average discount rate

 

 

 

 

3.20

%

 

Note 11. Stockholders' Equity

Effective January 27, 2015, the Company’s Board of Directors adopted the 2015 Stock Incentive Plan (the “2015 Plan”) which provides for up to 1,250,000 common shares available for issuance to provide a long-term incentive plan for officers, employees, directors and/or consultants to directly link incentives to stockholder value. The 2015 Plan was approved by the Company’s stockholders in February 2015. The Company’s 2015 Plan provides for grants to executives in various forms including restricted shares of the Company’s common stock and stock options. Awards are discretionary and are determined by the Compensation Committee of the Board of Directors. Awards vest based upon service conditions. Non-vested restricted shares generally vest over requisite service periods of one to six years from the date of grant.

The Company recognizes stock-based compensation expense for (i) Board of Directors fees (generally paid in treasury stock), and (ii) other awards under the 2015 Plan (paid in restricted stock and stock options). Stock-based compensation expense is recognized in general and administrative expenses in the Condensed Consolidated Statements of Operations.

Stock Compensation - Board of Directors

The Board of Directors can either elect to receive stock compensation or cash for their fees for services provided. Stock-based compensation expense relating to the Board of Director fees was approximately $222,000 and $193,000 for the three months ended December 31, 2020 and 2019, respectively.

Restricted Stock

Stock compensation expense related to the Restricted Stock of approximately $25,000 and $26,000 for the three months ended December 31, 2020 and 2019, respectively. There was approximately $159,000 and $0 of total unrecognized stock compensation costs related to unvested stock compensation for the Restricted Stock grants at December 31, 2020 and September 30, 2020, respectively.

16


 

On November 10, 2020, the Company awarded 5,885 restricted shares of the Company’s common stock (“Restricted Stock”) to certain executives and senior managers under the 2015 Plan at a weighted average fair value of $31.20 per common share, vesting on January 1, 2022.

Stock Option Grant

Stock option grants of 118,000 options to certain Officers and Managers of the Company (collectively the “2020 Option Grants”) were granted on October 11, 2019. The option exercise price was set at $33.96, the closing price on October 11, 2019. The 2020 Option Grants will vest as follows: (i) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $35.00; (ii) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $40.00; (iii) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $45.00; and (iv) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $50.00. If the applicable stock price hurdles have not been achieved by (A) the date that is 18 months following the termination of employment, if the employment is terminated due to death or disability, (B) the date that is 12 months following the termination of employment, if the employment is terminated by the Company without cause, by the employee with good reason, or due to the employee’s retirement, or (C) the date of the termination of employment for any other reason, then any unvested options will be forfeited. In addition, if the applicable stock price hurdles have not been achieved by December 31, 2022 then any unvested options will be forfeited. The 2020 Option Grants will also become vested to the extent that the applicable stock price hurdles are satisfied in connection with a change in control of the Company. During the three months ended December 31, 2020, the stock did not trade above $40.00 per share for twenty consecutive days (the $35.00 per share threshold was met during fiscal year 2020 and thus 25% was vested); accordingly, no additional amounts of the 2020 Option Grants vested at December 31, 2020.

Stock option grants of 10,000 options to Mr. John Kiernan (the “2019 Option Grants”) were granted on October 25, 2018. The option exercise price for these options was set at $33.34, the closing price on October 25, 2018. The 2019 Option Grants will vest as follows: (i) 3,333 of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $40.00; (ii) 3,333 of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $45.00; and (iii) 3,334 of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $50.00. If the applicable stock price hurdles have not been achieved by (A) the date that is 18 months following Mr. Kiernan’s termination of employment, if Mr. Kiernan’s employment is terminated due to death or disability, (B) the date that is 12 months following Mr. Kiernan’s termination of employment, if Mr. Kiernan’s employment is terminated by the Company without cause, by Mr. Kiernan with good reason, or due to Mr. Kiernan’s retirement, or (C) the date of the termination of Mr. Kiernan’s employment for any other reason, then any unvested options will be forfeited. In addition, if the applicable stock price hurdles have not been achieved by December 31, 2021 then any unvested options will be forfeited. The 2019 Option Grants will also become vested to the extent that the applicable stock price hurdles are satisfied in connection with a change in control of the Company. Since the date of grant the stock did not trade above $40.00 per share for twenty consecutive days; accordingly, none of the 2019 Option Grants are vested at December 31, 2020.

Stock option grants of 210,000 options to Mr. Remy Trafelet and 90,000 options to Mr. John Kiernan (collectively, the “2018 Option Grants”) were granted on September 7, 2018. The option exercise price for these options was set at $33.60, the closing price on September 7, 2018. The 2018 Option Grants will vest as follows: (i) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $35.00; (ii) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $40.00; (iii) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $45.00; and (iv) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $50.00. If the applicable stock price hurdles have not been achieved by (A) the date that is 18 months following the respective Executive’s termination of employment, if the respective Executive’s employment is terminated due to death or disability, (B) the date that is 12 months following the respective Executive’s termination of employment, if the respective Executive’s employment is terminated by the Company without cause, by the respective Executive with good reason, or due to the respective Executive’s retirement, or (C) the date of the termination of the respective Executive’s employment for any other reason, then any unvested options will be forfeited. In addition, if the applicable stock price hurdles have not been achieved by

17


 

December 31, 2021 then any unvested options will be forfeited. The 2018 Option Grants will also become vested to the extent that the applicable stock price hurdles are satisfied in connection with a change in control of the Company. During the three months ended December 31, 2020, the stock did not trade above $40.00 per share for a consecutive twenty days (the $35.00 per share threshold was met during fiscal year 2020 and thus 25% was vested); accordingly, no additional stock options of Mr. Kiernan's 2018 Option Grants vested at December 31, 2020. As set forth below, more than a majority of the 2018 Option Grants issued to Mr. Trafelet were forfeited and the vesting conditions of the remainder were modified, all pursuant to the Alico Settlement Agreement, as defined below.

A stock option grant of 300,000 options in the case of Mr. Trafelet and 225,000 options in the case of each of Mr. Henry Slack and Mr. George Brokaw (collectively, the “2016 Option Grants”) were granted on December 31, 2016.  The option price was set at $27.15, the closing price on December 31, 2016.  The 2016 Option Grants will vest as follows: (i) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $60.00; (ii) 25% of the options will vest if such price during a consecutive 20-trading day period exceeds $75.00; (iii) 25% of the options will vest if such price during a consecutive 20-trading day period exceeds $90.00; and (iv) 25% of the options will vest if such price during a consecutive 20-trading day period exceeds $105.00. If the applicable stock price hurdles have not been achieved by (A) the second anniversary of the Executive’s termination of employment, if the Executive’s employment is terminated due to death or disability, (B) the date that is 18 months following the Executive’s termination of employment, if the Executive’s employment is terminated by the Company without cause, by the Executive with good reason, or due to the Executive’s retirement, or (C) the date of the termination of the Executive’s employment for any other reason, then any unvested options will be forfeited. In addition, if the applicable stock price hurdles have not been achieved by the fifth anniversary of the grant date (or the fourth anniversary of the grant date, in the case of the tranche described in clause (i) above), then any unvested options will be forfeited. The 2016 Option Grants will also become vested to the extent that the applicable stock price hurdles are satisfied in connection with a change in control of the Company. Since the date of grant the stock did not trade above $60.00 per share for twenty consecutive days; accordingly, none of the 2016 Option Grants are vested at December 31, 2020. As set forth below, all of the 2016 Option Grants issued to Mr. Trafelet were forfeited pursuant to the Alico Settlement Agreement, as defined below.

Additionally, 187,500 shares of the 2016 Option Grants made to each of Messrs. Slack and Brokaw were forfeited on September 5, 2018 and no replacement options were granted.

Pursuant to an Alico Settlement Agreement dated February 11, 2019 (described in Note 13. “Related Party Transactions”), which was unanimously approved by the Board of Directors, Mr. Trafelet agreed to voluntarily resign from his roles as President and Chief Executive Officer and a director of the Company. Under the Settlement Agreement, Mr. Trafelet forfeited (i) all of the 2016 Option Grants granted to him and (ii) all of the 2018 Option Grants granted to him in September 2018, other than 26,250 stock options that were to vest if the minimum price of Alico's common stock over 20 consecutive trading days exceeded $35.00 per share and 26,250 stock options that were to vest if the minimum price of Alico's common stock over 20 consecutive trading days exceeded $40.00 per share (“2019 Modified Option Grant”), in each case, by the first anniversary of the date of the Alico Settlement Agreement (collectively, the "Retained Options"). Any Retained Options that vest in accordance with their terms were to expire on the date that is six months following the date on which the Retained Option vests, and any Retained Options that do not vest by the first anniversary of the Alico Settlement Agreement were to be forfeited as of such first anniversary. Although, by the first anniversary of the Alico Settlement Agreement, the Company’s common stock traded above $35.00 per share for a consecutive twenty days and thus 26,250 stock options from the 2019 Modified Options Grant vested, such Retained Options were not exercised within six months following the date on which such Retained Options vested, and accordingly they were forfeited. Additionally, since the stock did not trade above $40.00 per share for a consecutive twenty days by the first anniversary of the date of the Alico Settlement Agreement, the other 26,250 stock options from the 2019 Modified Option Grants never vested and were forfeited.

Forfeitures of all stock options were recognized as incurred.

18


 

Stock compensation expense related to the options of approximately $60,000 and $82,000 was recognized for the three months ended December 31, 2020 and 2019, respectively. At December 31, 2020 and September 30, 2020, there was approximately $316,000 and $376,000, respectively, of total unrecognized stock compensation costs related to unvested share-based compensation for the option grants. The total unrecognized compensation cost is expected to be recognized over a weighted-average period of 1.47 years.

The fair value of the 2020 and 2019 Option Grants was estimated on the date of grant using a Monte Carlo valuation model that uses the assumptions noted in the following table. The expected term of options granted is derived from the output of the option valuation model and represents the period of time that options granted are expected to be outstanding; the range given below results from different timeframes for the various market conditions being met.

 

2020 Option Grant

 

 

 

 

Expected Volatility

 

 

26.0

%

Expected Term (in years)

 

3.61

 

Risk Free Rate

 

 

1.60

%

 

The weighted-average grant-date fair value of the 2020 Option Grant was $3.20. There were no additional stock options granted or exercised for the three months ended December 31, 2020.

 

2019 Modified Option Grant

 

 

 

 

Expected Volatility

 

 

25.0

%

Expected Term (in years)

 

1.50

 

Risk Free Rate

 

 

2.52

%

 

The weighted-average grant-date fair value of the 2019 Modified Option Grant was $1.40.

 

2019 Option Grants

 

 

 

 

Expected Volatility

 

 

30.0

%

Expected Term (in years)

 

4.09

 

Risk Free Rate

 

 

2.95

%

 

The weighted-average grant-date fair value of the 2019 Option Grants was $7.10.

Stock Repurchase Authorizations

On October 10, 2019, the Board of Directors authorized the repurchase of up to 7,000 shares of the Company’s common stock from 734 Investors in a privately negotiated repurchase of shares; and on October 15, 2019, the Company entered into a repurchase agreement to repurchase a total of 7,000 shares of the Company’s common stock from 734 Investors, effective October 15, 2019.

The following table illustrates the Company’s treasury stock activity for the three months ended December 31, 2020:

 

(in thousands, except share amounts)

 

 

 

 

 

 

 

 

 

 

Shares

 

 

Cost

 

Balance as of September 30, 2020

 

 

923,621

 

 

$

30,779

 

Issued to employees and directors

 

 

(13,636

)

 

 

(358

)

Balance as of December 31, 2020

 

 

909,985

 

 

$

30,421

 

 

Note 12. Commitments and Contingencies

Letters of Credit

The Company had outstanding standby letters of credit in the total amount of approximately $236,000 and $399,000 at December 31, 2020 and September 30, 2020, respectively, to secure its various contractual obligations.

19


 

Legal Proceedings

From time to time, Alico may be involved in litigation relating to claims arising out of its operations in the normal course of business. There are no current legal proceedings to which the Company is a party or of which any of its property is subject that it believes will have a material adverse effect on its financial position, results of operations or cash flows.

Purchase Commitments

The Company enters into contracts for the purchase of citrus trees during the normal course of its business. As of December 31, 2020, the Company had approximately $2,955,000 relating to outstanding commitments for these purchases that will be paid upon delivery of the remaining citrus trees.

Note 13. Related Party Transactions

Henry R. Slack and George R. Brokaw

On December 31, 2016, the Company entered into new employment agreements (collectively, the “Employment Agreements”) with Henry R. Slack, and George R. Brokaw. Mr. Slack previously served as the Executive Chairman of the Company, and Mr. Brokaw previously served as the Executive Vice Chairman of the Company. The Employment Agreements provided for an annual base salary of $250,000 in the case of Mr. Slack and an annual base salary of $250,000 in the case of Mr. Brokaw.

Effective July 1, 2019, Mr. Slack resigned his employment with the Company as Executive Chairman. Effective December 31, 2019, Mr. Brokaw resigned his employment with the Company as Executive Vice Chairman.  Mr. Slack and Mr. Brokaw continue to serve on the Board of the Company.

Remy W. Trafelet

On February 11, 2019, as contemplated by a settlement agreement between the Company, certain members of the Board of Directors, Mr. Trafelet, and certain third parties affiliated with Mr. Trafelet (the “Alico Settlement Agreement”) Mr. Trafelet submitted to the Board his resignation as President and Chief Executive Officer of the Company and a member of the Board, effective upon the execution of the Alico Settlement Agreement. Also, on February 11, 2019, as contemplated by the Alico Settlement Agreement, the Company entered into a consulting agreement (the "Consulting Agreement") with Mr. Trafelet and 3584 Inc., an entity controlled by Mr. Trafelet (the "Consultant"). Pursuant to the Consulting Agreement, Mr. Trafelet will make himself available to provide consulting services to the Company through the Consultant for up to 24 months. In exchange for the consulting services, the Consultant will receive an annual consulting fee of $400,000. As of December 31, 2020, the Company has paid approximately $754,000 towards these consulting fees. If the Company terminates the consulting period (other than in certain specified circumstances), the Company will continue to pay the consulting fees described above through the balance of the 24-month term.

Distribution of Shares by Alico’s Largest Shareholder

On November 12, 2019, 734 Investors, the Company’s largest shareholder from 2013 until November 12, 2019, distributed the 3,173,405 shares of Company common stock held by it, on a pro rata basis, to its members. The Company understands this share distribution was made in anticipation of the dissolution of 734 Investors. Transfers of these shares were not made pursuant to any current Alico registration statement.

20


 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with the accompanying Condensed Consolidated Financial Statements and related Notes thereto.

Cautionary Statement Regarding Forward-Looking Information

We provide forward-looking information in this Quarterly Report on Form 10-Q, particularly in this Management’s Discussion and Analysis of Financial Condition and Results of Operations, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Any statements in this Quarterly Report on Form 10-Q that are not historical facts are forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on our current expectations, estimates and projections about our business based, in part, on assumptions made by our management and can be identified by terms such as “plans,” “expect,” “may,” "anticipate,” “intend,” “should be,” “will be” “is likely to,” “believes,” and similar expressions referring to future periods. Alico believes the expectations reflected in the forward-looking statements are reasonable but cannot guarantee future results, level of activity, performance or achievements. Actual results may differ materially from those expressed or implied in the forward-looking statements. Therefore, Alico cautions you against relying on any of these forward-looking statements. Factors which may cause future outcomes to differ materially from those foreseen in forward-looking statements include, but are not limited to: changes in laws, regulation and rules; weather conditions that affect production, transportation, storage, demand, import and export of fresh product and their by-products; increased pressure from diseases including citrus greening and citrus canker, as well as insects and other pests; disruption of water supplies or changes in water allocations; market pricing of citrus; pricing and supply of raw materials and products; market responses to industry volume pressures; pricing and supply of energy; changes in interest rates; availability of financing for land development activities and other growth and corporate opportunities; onetime events; acquisitions and divestitures; seasonality; labor disruptions; inability to pay debt obligations; inability to engage in certain transactions due to restrictive covenants in debt instruments; government restrictions on land use; changes in agricultural land values; impact of the COVID-19 outbreak and coronavirus pandemic on our agriculture operations, including without limitation demand for product, supply chain, health and availability of our labor force, the labor force of contractors we engage, and the labor force of our competitors; other risks related to the duration and severity of the COVID-19 outbreak and coronavirus pandemic and its impact on Alico’s business; the impact of the COVID-19 outbreak and coronavirus pandemic on the U.S. and global economies and financial markets; access to governmental loans and incentives; any reduction in the public float resulting from repurchases of common stock by Alico; changes in equity awards to employees; whether the Company's dividend policy, including its recent increased dividend amounts, is continued; the impact on the trading price of the Company’s common stock as a result of an expressed desire of certain of our shareholders to liquidate their shareholdings and sales of common stock and other future transactions designed to consummate such expressed desire; political changes and economic crises; competitive actions by other companies; increased competition from international companies; changes in environmental regulations and their impact on farming practices; the land ownership policies of governments; changes in government farm programs and policies and international reaction to such programs; changes in pricing calculations with our customers; fluctuations in the value of the U.S. dollar, interest rates, inflation and deflation rates; length of terms of contracts with customers; and changes in and effects of crop insurance programs, global trade agreements, trade restrictions and tariffs; the exercise of an option by the State of Florida to purchase approximately 5,804 acres of land from Alico; and soil conditions, harvest yields, prices for commodities, and crop production expenses. These forward looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including those Risks Factors described in our Annual Report on Form 10-K for the fiscal year ended September 30, 2020, and our Quarterly Reports on Form 10-Q.

21


 

Business Overview

Business Description

Alico, Inc., together with its subsidiaries (collectively, “Alico”, the “Company”, “we”, “us” or “our”) generates operating revenues primarily from the sale of its citrus products, providing services to citrus groves owned by third parties, and grazing and hunting leasing. The Company operates as two business segments and all of its operating revenues are generated in the United States. For the three months ended December 31, 2020, the Company generated operating revenues of approximately $13,732,000, income from operations of approximately $2,869,000, and net income attributable to common stockholders of approximately $3,845,000. Net cash used in operating activities was approximately $5,109,000 for the three months ended December 31, 2020.

Business Segments

Operating segments are defined in the criteria established under the Financial Accounting Standards Board - Accounting Standards Codification (“FASB ASC”) Topic 280 as components of public entities that engage in business activities from which they may earn revenues and incur expenses for which separate financial information is available and which is evaluated regularly by the Company’s chief operating decision maker (“CODM”) in deciding how to assess performance and allocate resources. The Company’s CODM assesses performance and allocates resources based on its operating segments.

The Company has two segments as follows:

 

Alico Citrus includes activities related to planting, owning, cultivating and/or managing citrus groves in order to produce fruit for sale to fresh and processed citrus markets, including activities related to the purchase and resale of fruit and value-added services, which include contracting for the harvesting, marketing and hauling of citrus; and

 

Land Management and Other Operations includes activities related to native plant sales, grazing and hunting leasing, management and/or conservation of unimproved native pastureland and activities related to rock mining royalties and other insignificant lines of business. Also included are activities related to owning and/or leasing improved farmland. Improved farmland is acreage that has been converted, or is permitted to be converted, from native pasture and which may have various improvements including irrigation, drainage and roads.

Critical Accounting Policies and Estimates

The discussion and analysis of the Company's financial condition and results of operations is based upon its unaudited condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires it to make certain estimates and judgments that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. Alico bases these estimates on historical experience, available current market information and on various other assumptions that management believes are reasonable under the circumstances. Additionally, the Company evaluates the results of these estimates on an on-going basis. Management’s estimates form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

See Note 1. “Description of Business and Basis of Presentation” to the condensed consolidated financial statements in Item 1 of Part I of this Form 10-Q for a detailed description of recent accounting pronouncements.

22


 

Recent Developments

The COVID-19 Pandemic

On March 11, 2020, the World Health Organization declared the current novel coronavirus outbreak (“COVID-19”) to be a global pandemic. In response to this declaration and the rapid spread of COVID-19 within the United States, federal, state and local governments throughout the country have imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures have had a significant adverse impact upon many sectors of the economy, including certain agriculture businesses.

For the protection of our employees in accordance with the Centers For Disease Control and Prevention (CDC) guidelines, the Company arranged to have the majority of office personnel work remotely and continues to do so, has taken steps to allow and encourage greater separation for our employed and contracted field workers and has worked with its harvesters, haulers and suppliers to minimize interactions. The Company continues to assess the situation on a routine basis.

To date, the Company has experienced no material adverse impacts from this pandemic.

Sale and Purchase of Land

On December 15, 2020 (the “Approval Date”), the State of Florida approved entering into an option agreement for sale and purchase (the “Option Agreement”) submitted by the Company which grants the State of Florida an option to purchase approximately 5,804 acres of Alico Ranch for approximately $14,600,000 (the “Exercise Price”) under the Florida Forever program (the “Option”). The State of Florida may exercise the Option any time beginning on the Approval Date until the 120th day after the Approval Date, subject to extension in accordance with the terms of the Option Agreement. The Option Agreement provides for certain adjustments to the Exercise Price; however, if the adjusted purchase price is less than the Exercise Price, the Company may, in its sole discretion, either approve the adjusted purchase price or terminate the Option Agreement.

On October 30, 2020, the Company purchased approximately 3,280 gross acres located in Hendry County for a purchase price of $16,450,000. This acquisition allows the Company to add additional scale to its existing 45,000 gross acres of citrus properties.  Strategically, with these acquired groves neighboring existing Alico groves, Alico believes that this acquisition will help Alico to its operation as a low-cost, high producing citrus grower.

Federal Relief Program

The Company was eligible for Hurricane Irma federal relief programs for block grants that were being administered through the State of Florida. During the fiscal years ended September 30, 2020 and 2019, the Company received approximately $4,629,000 and $15,597,000, respectively, under the Florida Citrus Recovery Block Grant (“CRBG”) program. These federal relief proceeds represented Part 1 and Part 2 reimbursement under the three-part program. In the quarter ended December 31, 2020, the Company received approximately $4,136,000, representing reimbursement under Part 3 of the program.


23


 

 

Condensed Consolidated Results of Operations

The following discussion provides an analysis of Alico's results of operations and should be read in conjunction with the accompanying Condensed Consolidated Statements of Operations for the three months ended December 31, 2020 and 2019:

 

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

December 31,

 

 

Change

 

 

 

2020

 

 

2019

 

 

$

 

 

%

 

Operating revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Alico Citrus

 

$

12,926

 

 

$

10,175

 

 

$

2,751

 

 

 

27.0

%

Land Management and Other Operations

 

 

806

 

 

 

830

 

 

 

(24

)

 

 

(2.9

)%

 Total operating revenues

 

 

13,732

 

 

 

11,005

 

 

 

2,727

 

 

 

24.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Alico Citrus

 

 

4,779

 

 

 

5,335

 

 

 

(556

)

 

 

(10.4

)%

Land Management and Other Operations

 

 

618

 

 

 

279

 

 

 

339

 

 

 

121.5

%

Total gross profit

 

 

5,397

 

 

 

5,614

 

 

 

(217

)

 

 

(3.9

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative expenses

 

 

2,528

 

 

 

2,760

 

 

 

(232

)

 

 

(8.4

)%

Income from operations

 

 

2,869

 

 

 

2,854

 

 

 

15

 

 

 

0.5

%

Total other income (expense), net

 

 

2,185

 

 

 

(1,595

)

 

 

3,780

 

 

NM

 

Income before income taxes

 

 

5,054

 

 

 

1,259

 

 

 

3,795

 

 

NM

 

Income tax provision

 

 

1,250

 

 

 

361

 

 

 

889

 

 

NM

 

Net income

 

 

3,804

 

 

 

898

 

 

 

2,906

 

 

NM

 

Net loss (income) attributable to noncontrolling interests

 

 

41

 

 

 

(107

)

 

 

148

 

 

NM

 

Net income attributable to Alico, Inc. common stockholders

 

$

3,845

 

 

$

791

 

 

$

3,054

 

 

NM

 

NM - Not meaningful

24


 

The following discussion provides an analysis of the Company's operating segments:

Alico Citrus

The table below presents key operating measures for the three months ended December 31, 2020 and 2019:

 

(in thousands, except per box and per pound solids data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

Change

 

 

 

2020

 

 

2019

 

 

Unit

 

 

%

 

Operating Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Early and Mid-Season

 

$

9,315

 

 

$

9,066

 

 

$

249

 

 

 

2.7

%

Fresh Fruit

 

 

409

 

 

 

735

 

 

 

(326

)

 

 

(44.4

)%

Purchase and Resale of Fruit

 

 

57

 

 

 

47

 

 

 

10

 

 

 

21.3

%

Grove Management Services

 

 

3,092

 

 

 

305

 

 

 

2,787

 

 

NM

 

Other

 

 

53

 

 

 

22

 

 

 

31

 

 

 

140.9

%

Total

 

$

12,926

 

 

$

10,175

 

 

$

2,751

 

 

 

27.0

%

Boxes Harvested:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Early and Mid-Season

 

 

785

 

 

 

880

 

 

 

(95

)

 

 

(10.8

)%

Total Processed

 

 

785

 

 

 

880

 

 

 

(95

)

 

 

(10.8

)%

Fresh Fruit

 

 

48

 

 

 

95

 

 

 

(47

)

 

 

(49.5

)%

Total

 

 

833

 

 

 

975

 

 

 

(142

)

 

 

(14.6

)%

Pound Solids Produced:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Early and Mid-Season

 

 

4,132

 

 

 

4,856

 

 

 

(724

)

 

 

(14.9

)%

Total

 

 

4,132

 

 

 

4,856

 

 

 

(724

)

 

 

(14.9

)%

Pound Solids per Box:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Early and Mid-Season

 

 

5.26

 

 

 

5.52

 

 

 

(0.26

)

 

 

(4.7

)%

Price per Pound Solids:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Early and Mid-Season

 

$

2.25

 

 

$

1.87

 

 

$

0.38

 

 

 

20.3

%

Price per Box:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fresh Fruit

 

$

8.52

 

 

$

7.74

 

 

$

0.78

 

 

 

10.1

%

Operating Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of Sales

 

$

7,420

 

 

$

6,627

 

 

$

793

 

 

 

12.0

%

Harvesting and Hauling

 

 

2,079

 

 

 

2,465

 

 

 

(386

)

 

 

(15.7

)%

Purchase and Resale of Fruit

 

 

50

 

 

 

32

 

 

 

18

 

 

 

56.3

%

Grove Management Services

 

 

2,734

 

 

 

182

 

 

 

2,552

 

 

NM

 

Other

 

 

(4,136

)

 

 

(4,466

)

 

 

330

 

 

 

(7.4

)%

Total

 

$

8,147

 

 

$

4,840

 

 

$

3,307

 

 

 

68.3

%

 

NM - Not meaningful

The Company sells its Early and Mid-Season and Valencia oranges to processors that convert the majority of the citrus crop into orange juice. The processors generally buy the citrus crop on a pound solids basis, which is the measure of the soluble solids (sugars and acids) contained in one box of fruit. The Company’s fresh fruit is generally sold to packing houses that purchase the citrus on a per box basis. The Company also provides citrus grove caretaking and harvest and haul management services to third parties in which revenues are recorded, including a management fee. Other revenues consist of the purchase and reselling of fruit.

Alico's operating expenses consist primarily of cost of sales and harvesting and hauling costs. Cost of sales represents the cost of maintaining the citrus groves for the preceding calendar year and does not vary in relation to production. Harvesting and hauling costs represent the costs of bringing citrus product to processors and varies based upon the number of boxes produced. Other expenses include the period costs of third-party grove caretaking and the purchase and reselling of third-party fruit.

 

25


 

 

The increase in revenue for the three months ended December 31, 2020, compared to the three months ended December 31, 2019 was primarily due to the Company generating greater revenue from its grove management services it provides to third parties. On July 16, 2020, the Company executed an agreement with an affiliated group of third parties to provide citrus grove caretaking and harvest and haul management services for approximately 7,000 acres owned by such third parties. Under the terms of this agreement, the Company is reimbursed by the third parties for all of its costs incurred related to providing these services and also receives a management fee based on acres covered under this agreement. The Company records both an increase in revenues and expenses as and when the Company provides these citrus grove caretaking management services. For the first quarter ended December 31, 2020, under this agreement, the Company recorded approximately $2,869,000 of operating revenue relating to these grove management services, including the management fee.

 

Additionally, the slight increase in revenues generated from the Early and Mid-Season harvest for the three months ended December 31, 2020, compared to the three months ended December 31, 2019, was driven by an increase in the market price per pound solids. The increase in the price per pound solids is due to increased consumption of Not from Concentrate Orange Juice (“NFC”), which has in turn led to reduced inventory levels. As reported by Nielsen data on January 11, 2021, NFC consumption has increased 14% for the twelve-week period ended December 26, 2020, as compared to the similar twelve-week period in the prior year.

 

Mostly offsetting this increase in pricing generated from the Early and Mid-Season harvest is fewer boxes being harvested as well as pound solids per box being lower for the three months ended December 31, 2020, compared to the three months ended December 31, 2019. While the Company has harvested a greater percentage of its Early and Mid-Season crop through December 31, 2020, measured as a percentage of its estimated full year Early and Mid-Season crop, as compared to the same period in the prior year, the Company, along with the Florida industry in general, is recording a smaller number of boxes harvested as a result of greater fruit drop rate during the current harvest season as compared to the previous year. In addition, the internal quality of the fruit was not as strong as in the previous year resulting in lower pound solids per box.

 

The Company harvest season to date has not been impacted by the COVID-19 pandemic.

 

The USDA, in its January 12, 2021 Citrus Crop Forecast for the 2020-21 harvest season, indicated its expectation that the Florida orange crop will decrease from approximately 67,300,000 boxes for the 2019-20 crop year to approximately 54,000,000 boxes for the 2020-21 crop year, a decrease of approximately 19.8%. The USDA anticipates the majority of this decrease relates to the Early and Mid-Season boxes as it has indicated its expectation is for a decrease of 9,650,000 boxes or a 32.6% decline. The Company, through its comprehensive grove management program, anticipates its decline in Early and Mid-Season crop will be in the range of 20-25%.

 

The increase in operating expenses for the three months ended December 31, 2020, as compared to the three months ended December 31, 2019, primarily relates to grove management services it provides to third parties. As mentioned above, on July 16, 2020, the Company executed an agreement with an affiliated group of third parties to provide citrus grove caretaking and harvest and haul management services for approximately 7,000 acres owned by such third parties. Under this agreement, for the first quarter ended December 31, 2020, the Company recorded approximately $2,631,000 of operating expenses relating to these grove management services. Additionally, the increase in operating expenses is attributable to the Company harvesting a greater percentage of boxes, in relation to the estimated total boxes to be harvested for the full season, in the three months ended December 31, 2020, as compared to the same period in the prior year, leading to a larger percentage of costs being allocated to cost of sales in the period. Partially offsetting this increase was a decrease in harvest and haul expenses attributable to a decrease in Early and Mid-season boxes harvested. Additionally, the Company received less proceeds under the CRBG program during the three months ended December 31, 2020, when compared to the three months ended December 31, 2019.

 

As a result of a lower gross profit percentage generated from grove caretaking management services, as compared to citrus sales generated from groves, the overall gross profit percentage within the Alico Citrus segment will be lower than prior to the execution of the above-mentioned new caretaking services agreement.

26


 

The credit amounts shown in “Other” in operating expenses above represents federal relief proceeds received under the CRBG program in the quarters ended December 31, 2020 and 2019.

Land Management and Other Operations

The table below presents key operating measures for the three months ended December 31, 2020 and 2019:

 

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

December 31,

 

 

Change

 

 

 

2020

 

 

2019

 

 

$

 

 

%

 

Revenue From:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Land and Other Leasing

 

$

727

 

 

$

663

 

 

$

64

 

 

 

9.7

%

Other

 

 

79

 

 

 

167

 

 

 

(88

)

 

 

(52.7

)%

Total

 

$

806

 

 

$

830

 

 

$

(24

)

 

 

(2.9

)%

Operating Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Land and Other Leasing

 

$

184

 

 

$

201

 

 

$

(17

)

 

 

(8.5

)%

Water Conservation

 

 

 

 

 

347

 

 

 

(347

)

 

 

(100.0

)%

Other

 

 

4

 

 

 

3

 

 

 

1

 

 

 

33.3

%

Total

 

$

188

 

 

$

551

 

 

$

(363

)

 

 

(65.9

)%

 

Land and other leasing include lease income from leases for grazing rights, hunting leases, a farm lease, a lease to a third party of an aggregate mine, leases of oil extraction rights to third parties, and other miscellaneous income.

 

The slight decrease in revenues from Land Management and Other Operations for the three months ended December 31, 2020, as compared to the three months ended December 31, 2019 is primarily due to a modification to a grazing lease whereby the ad valorem taxes due from the lessee were reduced as a result of the Company revising the grazing lease agreement due to the sale of certain ranch acres previously covered under the agreement. Partially offsetting this decrease were the additional revenues generated from the execution of an extension of one of Company’s cell tower leases pursuant to which the leasing rates were increased.

 

The decrease in operating expenses from Land Management and Other Operations for the three months ended December 31, 2020, compared to the three months ended December 31, 2019 is primarily due to the Company no longer pursuing its dispersed water storage project and, therefore, incurring no water conservation expenses in the three months ended December 31, 2020. On September 10, 2020, the Company sold approximately 10,700 acres on the western part of Alico Ranch to the State of Florida. Because the acres involved in the sale would have been critical to its planned dispersed water storage project, the Company has decided to no longer pursue permit approval activities for this particular project. Accordingly, the Company anticipates it will have no future expenses incurred relating to the dispersed water storage project.

 

General and Administrative Expense

 

General and administrative expense for the three months ended December 31, 2020 was approximately $2,528,000, compared to approximately $2,760,000 for the three months ended December 31, 2019. The decrease was attributable in large part to (i) a reduction in payroll expenses for the fiscal quarter ended December 31, 2020 of approximately $160,000 relating to one of the senior managers resigning in December 2019 and (ii) a reduction in pension expense related to the Company’s deferred retirement benefit plan of approximately $90,000 as a result of the Company terminating such plan and paying out each of the plan participants in August 2020.

 

27


 

 

Other Income (Expense), net

 

Other income (expense), net for the three months ended December 31, 2020 and 2019 was approximately $2,185,000 and approximately $(1,595,000), respectively. The shift to other income, net from other expense, net is primarily due to the Company recording, in the three months ended December 31, 2020, gains on sale of real estate, property and equipment and assets held for sale of approximately $3,364,000 relating to the sale of approximately 700 acres from the Alico ranch to several third parties and the sale of mineral rights to a third party in the three months ended December 31, 2020. For the three months ended December 31, 2019, the Company recorded a nominal gain on sale of real estate, property and equipment and assets held for sale. Additionally, a decrease in interest expense of $355,000 for the three months ended December 31, 2020, as compared to the three months ended December 31, 2019, was the result of the reduction of its long-term debt attributable to making its mandatory principal payments.

 

Income Taxes

 

The income tax provision was approximately $1,250,000 and $361,000 for the three months ended December 31, 2020 and 2019, respectively. The increase in the tax provision for the three months ended December 31, 2020 primarily resulted from the Company generating greater pre-tax income, compared to the three months ended December 31, 2019.

 

Seasonality

The Company is primarily engaged in the production of fruit for sale to citrus markets, which is of a seasonal nature, and subject to the influence of natural phenomena and wide price fluctuations. Historically, the second and third quarters of Alico’s fiscal year produce the majority of the Company's annual revenue. Working capital requirements are typically greater in the first and fourth quarters of the fiscal year, coinciding with harvesting cycles. Because of the seasonality of the business, results for any quarter are not necessarily indicative of the results that may be achieved for the full fiscal year.

Liquidity and Capital Resources

A comparative balance sheet summary is presented in the following table:

 

(in thousands)

 

December 31,

 

 

September 30,

 

 

 

 

 

 

 

2020

 

 

2020

 

 

Change

 

Cash and cash equivalents and restricted cash

 

$

2,601

 

 

$

19,687

 

 

$

(17,086

)

Total current assets

 

$

57,794

 

 

$

51,899

 

 

$

5,895

 

Total current liabilities

 

$

18,013

 

 

$

21,158

 

 

$

(3,145

)

Working capital

 

$

39,781

 

 

$

30,741

 

 

$

9,040

 

Total assets

 

$

430,182

 

 

$

423,937

 

 

$

6,245

 

Principal amount of term loans and lines of credit

 

$

157,766

 

 

$

151,193

 

 

$

6,573

 

Current ratio

 

3.21 to 1

 

 

2.45 to 1

 

 

 

 

 

 

Management believes that a combination of cash-on-hand, cash generated from operations, asset sales and availability under the Company's lines of credit will provide sufficient liquidity to service the principal and interest payments on its indebtedness and will satisfy working capital requirements and capital expenditures for at least the next twelve months and over the long term. Alico has a $70,000,000 working capital line of credit, of which approximately $57,560,000 is available for general use as of December 31, 2020, and a $25,000,000 revolving line of credit, all of which is available for general use as of December 31, 2020 (see Note 5. “Long-Term Debt and Lines of Credit" to the accompanying Condensed Consolidated Financial Statements). If the Company pursues significant growth and other corporate opportunities, such as the transaction whereby it acquired 3,280 citrus grove acres on October 30, 2020 for $16,450,000, it could have a material adverse impact on its cash balances and may need to finance such activities by drawing down monies under its lines of credit or by obtaining additional debt or equity financing. There can be no assurance that additional financing will be available to the Company when needed or, if available, that it can be obtained on commercially reasonable terms. Any inability to obtain additional financing could impact Alico's ability to pursue different growth and other corporate opportunities.

 

28


 

 

The level of debt could have important consequences on Alico's business, including, but not limited to, increasing its vulnerability to general adverse economic and industry conditions, limiting the availability of cash flow to fund future investments, capital expenditures, working capital, business activities and other general corporate requirements, and limiting flexibility in planning for, or reacting to, changes in its business and industry.

Net Cash Used In Operating Activities

The following table details the items contributing to Net Cash Used In Operating Activities for the three months ended December 31, 2020 and 2019:

 

(in thousands)

 

Three Months Ended

December 31,

 

 

 

 

 

 

 

2020

 

 

2019

 

 

Change

 

Net income

 

$

3,804

 

 

$

898

 

 

$

2,906

 

Depreciation, depletion, and amortization

 

 

3,851

 

 

 

3,609

 

 

 

242

 

Gain on sale of real estate, property and equipment and assets held for sale

 

 

(3,364

)

 

 

(25

)

 

 

(3,339

)

Loss on disposal of long-lived assets

 

 

443

 

 

 

88

 

 

 

355

 

Impairment of right-of-use asset

 

 

 

 

87

 

 

 

(87

)

Stock-based compensation expense

 

 

307

 

 

 

301

 

 

 

6

 

Change in working capital

 

 

(10,150

)

 

 

(11,001

)

 

 

851

 

Net cash used in operating activities

 

$

(5,109

)

 

$

(6,043

)

 

$

934

 

 

The decrease in net cash used in operating activities for the three months ended December 31, 2020, as compared to the same period in 2019, was primarily due to an increase in net income and an increase in inventory, which was related to the acquisition of the citrus acres purchased on October 30, 2020. Partially offsetting the decrease in net cash used in operating activities for the three months ended December 31, 2020, as compared to the same period in 2019, was an increase in gain on sale of real estate, property and equipment and assets held for sale in the three months ended December 31, 2020, relating to the sale of certain sections of the East Ranch. Additionally, the Company had a decrease in accounts payable and accrued expenses which was largely due to the timing of when expenses were incurred and paid.

Net Cash Used In Investing Activities

The following table details the items contributing to Net Cash Used In Investing Activities for the three months ended December 31, 2020 and 2019:

 

(in thousands)

 

Three Months Ended

December 31,

 

 

 

 

 

 

 

2020

 

 

2019

 

 

Change

 

Capital expenditures:

 

 

 

 

 

 

 

 

 

 

 

 

Citrus trees

 

$

(4,593

)

 

$

(3,349

)

 

$

(1,244

)

Equipment and other

 

 

(469

)

 

 

(192

)

 

 

(277

)

Total

 

 

(5,062

)

 

 

(3,541

)

 

 

(1,521

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition of citrus grove

 

 

(16,450

)

 

 

 

 

 

(16,450

)

Net proceeds from sale of real estate, property and equipment and assets held for sale

 

 

3,425

 

 

 

42

 

 

 

3,383

 

Change in deposits on purchase of citrus trees

 

 

64

 

 

 

(194

)

 

 

258

 

Advances on notes receivables, net

 

 

122

 

 

 

4

 

 

 

118

 

Other

 

 

25

 

 

 

 

 

 

25

 

Net cash used in investing activities

 

$

(17,876

)

 

$

(3,689

)

 

$

(14,187

)

 

The increase in the amount of net cash used in investing activities for the three months ended December 31, 2020, as compared to the three months ended December 31, 2019, was primarily due to the Company’s purchase of approximately 3,280 gross acres located in Hendry County for a purchase price of approximately $16,450,000. Partially offsetting this increase in capital expenditures were proceeds from the sale of certain sections of the East Ranch received during the three months ended December 31, 2019.


29


 

 

Net Cash Provided By (Used In) Financing Activities

The following table details the items contributing to Net Cash Provided By (Used In) Financing Activities for the three months ended December 31, 2020 and 2019:

 

(in thousands)

 

Three Months Ended

December 31,

 

 

 

 

 

 

 

2020

 

 

2019

 

 

Change

 

Repayments on revolving lines of credit

 

$

(14,187

)

 

$

 

 

$

(14,187

)

Borrowings on revolving lines of credit

 

 

23,449

 

 

 

 

 

 

23,449

 

Principal payments on term loans

 

 

(2,689

)

 

 

(7,132

)

 

 

4,443

 

Treasury stock purchases

 

 

 

 

 

(238

)

 

 

238

 

Dividends paid

 

 

(674

)

 

 

(448

)

 

 

(226

)

Deferred financing costs

 

 

 

 

 

(23

)

 

 

23

 

Net cash provided by (used in) financing activities

 

$

5,899

 

 

$

(7,841

)

 

$

13,740

 

 

The shift from cash used in financing activities to cash provided by financing activities is primarily due to the Company drawing down on its lines of credit during the three months ended December 31, 2020 to fund working capital, capital expenditures and other corporate items. Additionally, the Company made a prepayment of one of its long-term debt obligations in November 2019 in the amount of approximately $4,455,000.

Alico had approximately $12,204,000 outstanding on its revolving lines of credit as of December 31, 2020.

The WCLC line of credit agreement provides for Rabo Agrifinance, Inc. to issue up to $2,000,000 in letters of credit on the Company’s behalf. As of December 31, 2020, there was approximately $236,000 in outstanding letters of credit, which correspondingly slightly reduced Alico's availability under the line of credit.

Purchase Commitments

The Company enters into contracts for the purchase of citrus trees during the normal course of its business. As of December 31, 2020, the Company had approximately $2,955,000 relating to outstanding commitments for these purchases, which will be paid upon delivery.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

There have been no material changes during this reporting period in the disclosures set forth in Part II, Item 7A in our Annual Report on Form 10-K for the fiscal year ended September 30, 2020, as filed with the SEC on December 8, 2020.

Item 4. Controls and Procedures

 

(a)

Evaluation of Disclosure Controls and Procedures.

Our Principal Executive Officer and Chief Financial Officer have evaluated the effectiveness of our disclosure controls and procedures as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) as of the end of the period covered by this report. Based on this evaluation, our Principal Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective.

 

(b)

Changes in Internal Control over Financial Reporting.

During the fiscal quarter ended December 31, 2020, there were no changes in our internal controls over financial reporting that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

 

30


 

PART II - OTHER INFORMATION

From time to time, Alico may be involved in litigation relating to claims arising out of its operations in the normal course of business. There are no current legal proceedings to which the Company is a party or of which any of its property is subject that it believes will have a material adverse effect on its financial position, results of operations or cash flows.

Item 1A. Risk Factors

There have been no material changes in the risk factors set forth in Part 1, Item 1A, “Risk Factors” in Alico's Annual Report on Form 10-K for the fiscal year ended September 30, 2020, as filed with the SEC on December 8, 2020.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

There were no sales of unregistered equity securities during the period covered by this Quarterly Report on Form 10-Q.

There were no issuer purchases of the Company’s equity securities during the period covered by this Quarterly Report on Form 10-Q.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosure

Not Applicable.

Item 5. Other Information

None.

31


 

Item 6. Exhibits

 

Exhibit Number

 

Exhibit Index

 

 

 

    3.1

 

Restated Certificate of Incorporation, dated February 17, 1972 (incorporated by reference to Exhibit 3.1 of Alico's filing on Form 10-K dated December 11, 2017)

 

 

 

    3.2

 

Certificate of Amendment to Certificate of Incorporation, dated January 14, 1974 (incorporated by reference to Alico’s Registration Statement on Form S-8, dated December 21, 2005, Registration No. 333-130575)

 

 

 

    3.3

 

Amendment to Articles of Incorporation, dated January 14, 1987 (incorporated by reference to Alico’s Registration Statement on Form S-8, dated December 21, 2005, Registration No. 333-130575)

 

 

 

    3.4

 

Amendment to Articles of Incorporation, dated December 27, 1988 (incorporated by reference to Alico’s Registration Statement on Form S-8, dated December 21, 2005, Registration No. 333-130575)

 

 

 

    3.5

 

By-Laws of Alico, Inc., amended and restated (incorporated by reference to Exhibit 3.6 of Alico's filing on Form 8-K dated January 15, 2021)

 

 

 

  10.1

 

Eleventh Amendment and Waiver to Credit Agreement dated January 7, 2021

 

 

 

  10.2

 

Danny Sutton Offer letter, dated November 15, 2017

 

 

 

  31.1

 

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Rule 13a-14(a) certification

 

 

 

  31.2

 

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Rule 13a-14(a) certification

 

 

 

  32.1

 

Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350

 

 

 

  32.2

 

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350

 

 

 

101.INS

*

Inline XBRL Instance Document - The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document. 

 

 

 

101.SCH

*

Inline XBRL Taxonomy Extension Schema Document

 

 

 

101.CAL

*

Inline XBRL Taxonomy Calculation Linkbase Document

 

 

 

101.DEF

*

Inline XBRL Taxonomy Definition Linkbase Document

 

 

 

101.LAB

 

Inline XBRL Taxonomy Label Linkbase Document

 

 

 

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

104

 

The cover page for the Company’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2020, has been formatted in Inline XBRL.

*

 

In accordance with Rule 406T of Regulation S-T, these XBRL (eXtensible Business Reporting Language) documents are furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability under these sections.

 

 

 

 

32


 

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

 

ALICO, INC. (Registrant)

 

 

 

February 4, 2021

By:

/s/ John E. Kiernan

 

 

John E. Kiernan

 

 

President and Chief Executive Officer

 

 

(Principal Executive Officer)

 

 

 

 

 

 

February 4, 2021

By:

/s/ Richard Rallo

 

 

Richard Rallo

 

 

Senior Vice President and Chief Financial Officer

 

 

(Principal Financial and Accounting Officer)

 

33